Adaptation of A/Mallard/Potsdam/178-4/83 (H2N2) in Japanese quail leads to Replication and Transmission in Chickens by Sorrell, Erin Maureen
ABSTRACT
Title of Thesis: ADAPTATION OF
A/MALLARD/POTSDAM/178-4/83 (H2N2)
IN JAPANESE QUAIL LEADS TO
REPLICATION AND TRANSMISSION IN
CHICKENS
Erin Maureen Sorrell, Master of Science, 2005
Thesis Directed By: Assistant Professor Daniel R. Perez
Department of Veterinary Medicine
VA-MD Regional College of Veterinary
Medicine and The University of Maryland,
College Park
Influenza is a single stranded, negative-sense RNA virus with a segmented
genome that can infect avian and mammalian species.  Influenza viruses from the
avian reservoir do not seem to replicate efficiently in humans upon direct
transmission.  Therefore, an intermediate host is involved in generating mutations to
create a more transmissible or an avian-human reassortant virus.
Quail have been highlighted as a potential reservoir and intermediate host of
avian influenza.  To assess the potential of quail as an intermediate host,
A/Mallard/Postdam/178-4/83, H2N2 was tested to determine if through adaptation in
quail a mallard strain can replicate and transmit in quail, as well as other avian
species.  After six serial passages of lung homogenate a virus arose, which replicated
and transmitted directly to contact quail.  When chickens were infected with this
quail-adapted virus replication and transmission were observed, while no replication
was noted in the chickens infected with wild type H2N2 virus.
ADAPTATION OF A/MALLARD/POTSDAM/178-4/83 (H2N2)
IN JAPANESE QUAIL LEADS TO  REPLICATION AND TRANSMISSION IN
CHICKENS
By
Erin Maureen Sorrell
Thesis submitted to the Faculty of the Graduate School of the
University of Maryland, College Park, in partial fulfillment
of the requirements for the degree of
Master of Science
2005
Advisory Committee:
Assistant Professor Daniel Perez Chair/ Advisor
Associate Professor Jeffrey DeStefano
Professor Mary Ann Ottinger
Professor Siba Samal
Assistant Professor Xiaoping Zhu
© Copyright by
Erin Maureen Sorrell
2005
ii
ACKNOWLEDGMENTS
My parents not only raised me with love, they taught me to be an independent person.
Each in their own way showed me how to be strong, intelligent and to reach for your
goals.  I am here, writing this acknowledgement because of them.
I worked with many intelligent, perceptive scientists in my lab and I want to thank
each and every one, Dr. Haichen Song, Dr. Hongquan Wan, Sharon Azogue, Dr.
Gloria Ramirez Nieto, Dr. Xiaoyuan Huang, Dr. Annabelle Pascua and Dr. Jaber
Hossain.   I would especially like to thank my advisor, Dr. Daniel Perez, who gave
me ideas and let me build on them.  He pushed me forward in my thinking and
introduced me to a world of research and opportunities I had not known.  I would also
like to thank Dr. Haichen Song who has become my mentor.  She is a terrific scientist
and teacher and I thank her for all the time and instruction she has given me.
Thank you to my committee members, Dr. Siba Samal, Dr. Xiaoping Zhu, Dr. Mary
Ann Ottinger and Dr. Jeffrey DeStefano whose guidance and intellect have made my
research stronger.  I would also like to thank the department of Veterinary Medicine.
The faculty, students and staff provide a wonderful working environment.
iii
My friends and family have been there with me through it all.  They have read books
on influenza, learned about the CDC and WHO and are always ready to listen to me
ramble on about my newest experiment or finding.  My sisters, Colleen and Megan,
have been the encouragement and support necessary for a life of graduate work. They
are both intelligent women who are living examples of how to be respected and
valued for what you can bring to the table.  Patrick, you have always believed in me.
Thank you for making life fun, I know laughter will always be a part of life with you.
How does one say thank you to a group who has given up their life for science?  To
all the quail, chickens and ducks that worked with me, I am ever in debt to you.
Your sacrifice not only gave me my M.S. but will save many more avian lives in the
future. A big thank you to Emma Lavoie and Michael Quinn for all their help with
setting eggs and hatching all the quail used for this study and many others in our lab.
iv
TABLE OF CONTENTS
ACKNOWLEDGMENTS ............................................................................................ ii
TABLE OF CONTENTS............................................................................................. iv
List of Tables ............................................................................................................... vi
List of Figures ............................................................................................................. vii
List of Abbreviations ................................................................................................. viii
One-Letter Abbreviations for Amino Acids ................................................................ ix
Influenza Genes and Their Function............................................................................. x
CHAPTER 1, INTRODUCTION ................................................................................. 1
1.1 General Introduction ........................................................................................... 1
1.2 Research Objectives and Outline ........................................................................ 2
CHAPTER 2, LITERATURE REVIEW ...................................................................... 5
2.1 Influenza Virus.................................................................................................... 5
2.1.1 History and Pandemics ................................................................................ 5
2.1.2 Discovery of Influenza Viruses ................................................................... 8
2.1.3 Types of Influenza: A, B, C ......................................................................... 9
2.1.4 Propagation of Influenza............................................................................ 10
2.1.5 Morphology and Nature of the Genome .................................................... 11
2.2 Transmission of Influenza................................................................................. 11
2.2.1 Species and Subtype Variation .................................................................. 11
2.2.2 Antigenic Shift & Drift .............................................................................. 14
2.3 Influenza Life Cycle ......................................................................................... 16
2.3.1 Myxoviruses............................................................................................... 16
2.3.2 Virus Entry................................................................................................. 18
2.3.3 Viral mRNA Synthesis .............................................................................. 22
2.3.4 vRNA Replication...................................................................................... 23
2.3.5 Transport and Assembly ............................................................................ 26
2.4 Host Range of Influenza ................................................................................... 29
2.4.1 Molecular Determinants of Host-cell Restriction ...................................... 29
2.4.2 Interspecies Transmission.......................................................................... 31
2.4.3 Quail as Potential Intermediate Hosts........................................................ 34
CHAPTER 3, MATERIALS AND METHODS ........................................................ 40
3.1 Influenza Virus.................................................................................................. 40
3.2 Animals and experimental infections................................................................ 40
3.3 Transmission of influenza virus in quail........................................................... 45
3.4 Adaptation if mallard H2N2 virus in quail ....................................................... 45
3.5 Dose Preparations ............................................................................................. 48
3.6 Location of virus replication and shedding of WT and Quail-adapted H2N2.. 49
3.7 RT-PCR and sequencing................................................................................... 50
3.8 Hemagglutinin Assays ...................................................................................... 54
v3.9 Transmission of quail-adapted virus in chickens.............................................. 54
3.10 Weight Study .................................................................................................. 56
3.11 Infectious Dose 50 Studies.............................................................................. 56
3.12 Replication in Mallard Ducks ......................................................................... 57
3.13 Plaque Assays ................................................................................................. 58
CHAPTER 4, RESULTS............................................................................................ 59
4.1 Transmission of A/Mallard/Potsdam/178-4/83 (H2N2), in Quail .................... 59
4.2 Adaptation of A/Mallard/Potsdam/178-4/83 (H2N2) in Quail......................... 59
4.3 Location of viral replication and shedding ....................................................... 63
4.4 Adaptation of mallard influenza virus creates a strain capable of transmitting to
other terrestrial avian species.................................................................................. 63
4.5 Infectious Dose 50 Studies................................................................................ 68
4.6 RT-PCR and Sequencing of the WT A/Mallard/Potsdam/178-4/83 (H2N2) and
Quail-adapted Virus ................................................................................................ 68
4.7 Amino Acid Changes in Adaptation: Comparison to Contact Quail in Passage 8
and Contact Chickens Infected with Quail-adapted H2N2..................................... 69
4.8 Clinical Symptoms Associated with Infection of Quail-adapted H2N2 in quail
and chickens............................................................................................................ 72
4.9 Plaque Assays ................................................................................................... 72
CHAPTER 5, DISCUSSION...................................................................................... 75
CHAPTER 6, CONCLUSIONS AND FUTURE WORK.......................................... 91
6.1 Conclusions....................................................................................................... 91
6.2 Future Work ...................................................................................................... 93
REFERENCES ........................................................................................................... 95
vi
List of Tables
Table 1 Infection Study Endpoints ............................................................................. 43
Table 2, Score Table for Daily Observations in Poultry............................................. 44
Table 3, Dosing for Adaptation Study ........................................................................ 47
Table 4, Primers designed for sequencing .................................................................. 52
Table 5, Transmission of WT H2N2 and Quail-adapted Virus in Quail .................... 61
Table 6, Viral Shedding in Quail, Passages 1-8.......................................................... 62
Table 7, Replication and Transmission in White Leghorn Chickens ......................... 65
Table 8, Replication of WT H2N2 versus Quail-adapted H2N2 in mallard ducks .... 66
Table 9, Viral Titers from Quai, Chickens and Ducks ............................................... 67
Table 10, Comparison of Amino Acid changes.......................................................... 70
Table 11, Synonymous Changes from Adaptation in Quail ....................................... 71
vii
List of Figures
Figure 1.  Influenza Viral Attachment and Entry ....................................................... 21
Figure 2, Weight Study in Quail Infected with Quail-adapted H2N2 ........................ 73
Figure 3, Weight Study in Chickens Infected with Quail-adapted H2N2 .................. 74
Figure 4, Two-way Transmission of Avian Influenza Viruses................................... 79
Figure 5, Structures of Alanine (A), Valine (V) and Isoleucine (I) ............................ 86
viii
List of Abbreviations
Antb antibiotic / antimycotic
oC degrees Celsius
cDNA compliment DNA
cRNA compliment RNA
CDC Centers for Disease Control
EID50 egg infectious dose 50
HA Assay hemagglutinin assay
HEF hemagglutinin-esterase fusion
HPAI high pathogenic avian influenza
LPAI low pathogenic avian influenza
MDCK Mandin Darby Canine Kidney
ml milliter
mRNA messenger RNA
nt nucleotide
PBS phosphate-buffered saline
RT-PCR reverse transcriptase-polymerase chain reaction
µl microliter
vRNP viral ribonucleoprotein
vRNA viral RNA
WHO World Health Organization
WT wild type
ix
One-Letter Abbreviations for Amino Acids
G Glycine
A Alanine
V Valine
L Leucine
I Isoleucine
M Methonine
F Phenylanine
W Tryptophan
P Proline
S Serine
T Threonine
C Cysteine
Y Tyrosine
N Asparagine
Q Glutamine
K Lysine
R Arginine
H Histidine
D Aspartic Acid
E Glutamic Acid
xInfluenza Genes and Their Function
Gene                Segment          Size (nt)                   Function
PB2      1   2341 Transcriptase: cap binding
PB1      2   2341 Transcriptase: elongation
PA      3   2233 Transcriptase: vRNA replication
HA      4   1778 Hemagglutinin: Host cell attachment
NP      5   1565 Nucleoprotein: RNA binding, part of 
                 transcriptase complex, nuclear / cytoplasmic 
                 transport of vRNA
NA      6   1413 Neuraminidase: viral release
M      7   1027 Matrix:  M1 major component of virion
M2 integral membrane protein-ion
channel
NS 8    890 Nonstructural: NS1 nucleus; effects on
                                                                 cellular RNA transport, splicing, translation.
                                                                 Anti-interferon protein
            NS2 also known as NEP (nuclear export
                            protein)
1CHAPTER 1, INTRODUCTION
1.1 General Introduction
Molecular alterations in the genome of avian influenza viruses from wild birds are
thought to be required before these strains can infect humans (Beare and Webster,
1991; Hinshaw et al., 1983).  Intermediate hosts that are susceptible to influenza
viruses from aquatic birds can generate novel strains.  These strains have the potential
to cross the species barrier a second time. Therefore, identifying potential
intermediate hosts and the molecular changes associated to adaptation of influenza
viruses is vital if we want to prepare for and potentially prevent the emergence of
influenza strains with pandemic potential.  This research has evaluated the role that
quail could play as an intermediate host in which an influenza virus can change its
phenotypic characteristics and increase its host range.  This study shows that quail
could be such a host.
Japanese Quail (Coturnix coturnix), among other terrestrial birds, are extensively
farmed around the world.  Until a few years ago, quail were underrated and ignored
as a potentially important reservoir of avian influenza viruses.  In 1997 with the direct
transmission of avian H5N1 influenza to humans, extensive analysis of avian
influenza samples was conducted.  Analysis highlighted a quail H6N1 influenza virus
whose internal genes were identical to the 6 internal genes of the human H5N1 virus.
2Further investigation and molecular characterization of influenza virus strains isolated
from quail in Hong Kong and other parts of Southeast China showed that many of
these viruses were phylogenetically related to those that gained the capacity to cross
to humans, particularly H9 and H5 subtypes (Chin et al., 2002; Guan et al., 2000;
Hoffmann et al., 2000).  As a result, quail were banned from live bird poultry markets
in Hong Kong in 2002 under the suspicion that they were a contributing factor in the
perpetuation of avian influenza viruses in the markets.
However, quail remain a part of live bird markets around the world including
Europe and North America.  Infections in quail with avian influenza viruses is almost
unequivocally established in the respiratory tract and transmitted by aerosol, two
features in common to influenza viruses that have become endemic in humans and
swine.  Based on these observations we have hypothesized that quail provide an
environment where influenza viruses from the natural reservoir, wild aquatic birds,
could change their phenotypic characteristics and increase their host range.
1.2 Research Objectives and Outline
The main goal of this research is a study of adaptation with influenza virus,
A/Mallard/Potsdam/178-4/83 (H2N2), in Japanese quail and its subsequent ability to
transmit to other land-based birds.
3The research objectives of my thesis are to:
I. To determine whether A/Mallard/Potsdam/178-4/83 (H2N2) replicates but
can not transmit in Japanese Quail.
II. Adapt A/Mallard/Potsdam/178-4/83 in quail by serially passing the virus
in lung homogenate from the previous passage.  Confirm transmission
through direct contact with sentinel cage mates.
III. Determine if adaptation of a mallard virus in quail creates a virus better
adapted to other land-based birds as well as being able to infect the
original host.
IV. Determine the changes necessary, at the molecular level, for adaptation
and transmission of A/Mallard/Potsdam/178-4/83 (H2N2) in quail.
The results of my research are:
I. A/Mallard/Potsdam/178-4/83 (H2N2) established an infection in quail
directly inoculated with the virus and shed until day 3 post-infection.  No
transmission to sentinel cage mates was observed.
4II. After six passages of lung homogenate a virus arose that was adapted to
quail.  Transmission to contact quail occurred on day 3 post-infection and
all contact quail became infected shedding just as much virus as the
infected quail.
III. Quail-adapted H2N2 virus established an infection and transmitted to
White Leghorn chickens while in contrast the original, wild type,
A/Mallard/Postdam/178-4/83 was unable to establish an infection even in
chickens directly inoculated with virus.  Quail-adapted H2N2 was able to
establish an infection in mallard ducks.
IV. Changes occurred at both surface and internal genes, including the HA,
PB2, PB1 and NP genes.
5CHAPTER 2, LITERATURE REVIEW
2.1 Influenza Virus
2.1.1 History and Pandemics
Influenza viruses can cause serious outbreaks of upper-respiratory infections
in humans and other species.  The history of influenza dates back to 412 BC when
Hippocrates described an outbreak of flu-like illness that wiped out the Athenian
army (Hoehling, 1961).  Today influenza viruses are subdivided into types A, B, and
C.  Influenza A is the most contagious and caused the most human illnesses even
leading to a number of pandemics claiming millions of lives.
The first recorded European pandemic was 1173-74 although the first
generally accepted pandemic occurred between 1510 and1580 (Hoehling, 1961).
Since then there have been 31 documented pandemics although it is impossible to
clearly identify the early history of flu with any certainty.  Historical data gathered
from 1500 through 1800 collected by Webster and Hirsch outlined a pattern for
influenza epidemics.  There were three major observations.   Epidemics occurred
frequently however at irregular intervals and occasionally the disease disappeared for
periods of time, epidemics varied in severity usually causing mortality in the elderly
and some epidemics, particularly those that occurred in 1781 and 1830 appeared to
spread across Russia from Asia.
6There appears to have been two pandemics in the 19th century, occurring in
1847 and 1889.  The 1889 pandemic marked the beginning of modern epidemiology.
Influenza pandemics occurred every 18-34 years during 1510-1889 and between
1889-1977 they occurred every 9-39 years. Pandemics this century have occurred in
1918, 1957 and 1968.  After 1889, influenza became and remained an important
cause of mortality and morbidity.  It has been suggested from the 1889 pandemic a
major change occurred in epidemiology and for the next 25 years epidemics occurred
at irregular intervals and were associated with increased mortality.  The baseline rate
never returned to pre-1889 levels (Stuart-Harris et al., 1976).
In modern human history the most serious pandemic occurred in 1918.  It was
referred to as the “Spanish Flu” although the pandemic is thought to have originated
in China (Cox and Subbarao, 2000).  The virus then became known as the “Spanish
flu” because the country was the first to report an epidemic.  All armies of Europe
were hit hard by the outbreak, 80% of the U.S Army’s war deaths were due to
influenza.  After the initial infection influenza spread over America at alarming speed
with over 100,000 cases reported nationally in the first month.
Almost every country was affected by this pandemic.  The second and third
waves of the pandemic were associated with a large number of deaths, claiming
roughly 50% mortality in the 20 to 30 age group (Stuart-Harris et al., 1976).  In 1919
during the third wave the virus began to run its course and disappeared almost as
7rapidly as it began.  It is estimated that the pandemic that was of a H1N1 subtype,
killed more than 40 million people worldwide (Cox and Subbarao, 2000).
Up until the 1950s the H1N1 virus was still endemic all over the world.   In
1957 there was another influenza pandemic, the “Asian Flu”.  The virus was a H2N2
subtype, which originated from China.  The 1957 pandemic was a reassortant of the
1918 H1N1 and an avian H2N2 strain.  The hemagglutinin (HA), neuraminidase
(NA) and polymerase (PB1) genes of the H2N2 were of avian origin and the
remaining 5 genes from the human H1N1 (Kawaoka, Krauss, and Webster, 1989;
Scholtissek et al., 1978).  The emergence of the H2N2 led to the disappearance of the
H1N1 virus.  There were two waves to the 1957 pandemic with extreme mortality
occurring in each (Cox and Subbarao, 2000).
The third influenza pandemic of the 20th century occurred in 1968.  This
pandemic was caused by a H3N2 virus, later known as the “Hong Kong Flu”, it was a
result of the HA and PB1 of an H3 avian strain and the remaining genes from the ’57
H2N2 (Kawaoka, Krauss, and Webster, 1989; Scholtissek et al., 1978).  In 1977 the
re-emergence of the H1N1 influenza virus caused a mild pandemic.  The virus arose
in China and spread throughout the world mainly infecting those born after 1957.
Since then mild influenza epidemics caused by the H1N1 and H3N2 viruses have
been reported.
8In May1997 H5N1 emerged as an avian influenza strain that during the course
of seven months infected 18 people and of those, killed 6 (Subbarao et al., 1998;
Yuen et al., 1998).  To battle this avian to human transmission the Hong Kong
government ordered a mass culling of poultry in chicken farms and markets.   Recent
outbreaks of H5N1 viruses in Southeast Asia are affecting its victims at alarming
speed; almost a 70% mortality rate is associated with this virus (www.CDC.gov).
The incapability of this strain to transmit human to human is still a concern for
virologist and influenza surveillance, once it has mutated to become capable of
transmitting from human to human this strain has all the makings of a pandemic.
Avian influenza is a disease that ranges from a mild, possibly asymptomatic
infection to an acute, fatal disease of chickens, turkeys, guinea fowl, quail, and other
avian species, especially migratory water fowl.  Fowl plague was described in Italy in
1878, but it was not until 1955 that the fowl plague virus was identified as an
influenza virus (Schaeffer, 1955).   Once domestic birds are infected, avian influenza
outbreaks are nearly impossible to control and often lead to major economic impacts
including the loss of millions of chickens through culling.
2.1.2 Discovery of Influenza Viruses
In the 1880s and 1890s it became possible to culture bacteria and using the
method organisms such as Vibrio cholerae were discovered and shown to cause
epidemic diseases such as cholera.  Therefore, scientists looked for a characteristic
9bacterium that caused influenza.  The epidemic of 1889 presented an opportunity to
identify the causative agent if it were bacterium.  In the early 1900s the concept of
pathogenic filterable viruses was established by a method of isolation through the
filtration of bacteria and then reproducing the disease by inoculating plants or
animals.
It was in 1933 that Christopher Andrewes demonstrated that a filterable virus
was present that could be transmitted serially from ferret to ferret causing an immune
response protecting them from re-infection (Smith and Stuart-Harris, 1933).  Francis
and Magill independently isolated a new type of influenza virus, using ferrets and
mice, which had no antigenic relation to the previous isolates (Francis 1940).  The
new virus was referred to as type B, while the previously isolated virus was type A.
Influenza viruses were successfully grown in embryonated chicken eggs
(Smith 1935).  The use of egg isolation led to the discovery of the third type of
influenza virus in humans, type C.  It is a mild, nondescript common cold that occurs
sporadically and not in recognizable epidemics.  Type C is significantly different at
the biological level from influenza types A and B.
2.1.3 Types of Influenza: A, B, C
The structures of A and B viruses are very similar.  The main difference
between types A and B is the membrane channel lining the lipid envelope.  In
influenza A it is the M2 protein and in influenza B it is the NB protein.  The
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membrane channel for influenza C is the CM2 protein.  A and B viruses also differ in
their genome size with 14,639 nucleotides for type B and 13,588 nucleotides for A.
The difference in genome size is not due to the size of the proteins, rather it is
because of larger noncoding sequences in type B viruses.   The major characteristic
identifying type C versus types A and B is that influenza C has only one surface
glycoprotein and contains only seven RNA segments.  The surface glycoprotein in C,
referred to as the hemagglutinin-esterase fusion (HEF) protein contains the fusion and
receptor properties of A and B’s HA gene as well as the receptor destroying activity
of NA.  This enzymatic activity is not a neuraminidase but an esterase activity.  The
HEF protein has the same morphology as A and B’s HA.
2.1.4 Propagation of Influenza
Influenza viruses can be grown in embryonated chicken eggs or in primary
tissue culture systems (Smith, 1935; Burnet, 1936).  Egg inoculation is still used
today and is the system of choice for vaccine production and the acquisition of a large
volume of virus stock used for laboratory studies.  Isolation of human viruses through
tissue culture systems from either primary monkey kidney or Mandin Darby Canine
Kidney (MDCK) cells is well established.  Most human and avian influenza viruses
can be grown in eggs and detected through the agglutination of erythrocytes (Hirst
1941).  The surface glycoproteins of the virus bind sialic acid receptors on
erythrocytes causing the agglutination.  Influenza will replicate, cause cytopathology
and produce plaques in many primary tissue cultures.  However few cell systems
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other than primary kidney cells are suitable for plaque formation unless trypsin is
added to cleave the HA, activating the virus.
2.1.5 Morphology and Nature of the Genome
Influenza particles are highly pleiomorphic.  The morphological
characteristics of influenza viruses are a genetic trait but spherical morphology
depends on passage in eggs or tissue culture (Kilbourne, 1963).  Most influenza
viruses isolated from humans and other species after a single passage in culture show
great shape and size variation in contrast to viruses from infected eggs or tissue
culture fluids, which reveal irregularly shaped, spherical particles.  The majority of
viruses are found to be spherical, 80-120 nm in diameter but many forms occur,
including filamentous particles up to 2000 nm long.  Different strains of virus tend to
have different filamentous forms, a property which maps to the matrix protein, which
lines the inside of the viral envelope (Hay, 1974; Klenk, 1974).
2.2 Transmission of Influenza
2.2.1 Species and Subtype Variation
Representatives from each of the known subtypes of influenza A have been
isolated in aquatic birds, the virus’ natural reservoir.  Influenza viruses have been
isolated worldwide from domestic and wild avian species.  The largest number of
12
viruses have been gathered from feral water birds including ducks, geese, terns and
gulls as well as from a large group of domestic terrestrial birds like turkeys, chickens,
quail and pheasants (Easterday, 1975).  Influenza B viruses are restricted to humans
while type C viruses have been isolated from humans and pigs.
The clinical symptoms associated with influenza infections in avian species
range considerably with each strain of the virus.  Infections with most strains cause
asymptomatic infections though a few can cause disease including systemic infections
with CNS involvement and mortality within a week of infection.  The strains, which
cause this pathogenic infection in the birds, are of the H5 and H7 subtypes and are
referred to as highly pathogenic avian influenza strains (HPAI).  The major concern
with mallard viruses is the transmission of these strains to domestic birds, especially
those housed outdoors or in free range environments where the fecal material from
wild, migratory birds are accessible to the chickens, turkeys or quail in the outdoor
pens.  These outbreaks not only jeopardize the health of the particular flock infected
but also those of surrounding flocks and those who work with the birds.  Economic
losses as well as political uneasiness also play roles in each outbreak here in the U.S.
and across the globe.
In ducks the majority of viruses replicate in the cells lining the intestinal tract
while there is some replication in lung epithelial cells (Webster et al., 1978).  The
virus gains access by passage in the digestive tract, despite the low pH of the gizzard,
and are shed in high concentrations in the feces.  The mechanism by which influenza
13
infections can persist and spread in ducks from year to year is not well understood.
Influenza has been shown to infect juvenile birds when they congregate prior to
migration and those viruses can then persist in water surrounding those areas.  Some
ducks may shed virus, asymptomatically, up to 30 days therefore requiring few
passages to maintain the virus in population.  Current and available information
supports the continuous circulation of influenza in migrating waterfowl (Webster et
al., 1992).  The avirulent nature of avian influenza in its reservoir is the result of
adaptation over many centuries, creating an environment that allows the perpetuation
and evolution of this virus.  Avian influenza from ducks has been linked to outbreaks
in mammals including seals, whales, pigs, horses, ferrets, cats (domesticated and
wild), some breeds of dogs, as well as in other poultry species like chicken and quail
(Guo et al., 1992; Hinshaw et al., 1986; Scholtissek et al., 1983; Webby, Hoffmann,
and Webster, 2004; Webster et al., 1981).
Studies on the ecology of the virus show that all mammalian influenza viruses
derive from the avian reservoir (Reid et al., 1999; Reid et al., 2002; Reid et al., 2000).
Phylogenetic analysis of the NP protein show avian influenza has evolved into five
host-specific lineages.  They are an ancient equine lineage (not isolated in the last 25
years), a recent equine lineage, a lineage in gulls, one in swine and one in humans.  It
appears the ancestor of the swine and human viruses is one of avian origin, one that
derived all eight of its genes from avian sources (Reid et al., 2004; Webster et al.,
1992).  Studies with the NP and other gene segments indicate separate sublineages of
influenza in Eurasia and the Americas, demonstrating birds with a longitudinal
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migration path play a role in the transmission of these viruses (Liu et al., 2004;
Makarova et al., 1999; Schafer et al., 1993).  Influenza virus evolution in avian
reservoirs has reached stasis.  There is no evidence of net evolution in the past 60 +
years.  Nucleotide changes continue to occur at similar rates to mammalian viruses
but these changes no longer lead to amino acid changes, thus referred to as
synonymous changes. This level of conservation suggests that avian viruses are
approaching an adaptive optimum.  The source of pandemic viruses exist
phenotypically unchanged in the aquatic bird, implicating that silent nucleotide
changes dominate over deleterious or neutral amino acid changes (Reid et al., 2004).
Influenza A viruses in humans follow a single branch lineage, indicating no
co-circulating strains of the same subtype so that the virus evolves by clonal
reconstitution following the previous outbreak’s extinction (Buonagurio et al., 1985).
Influenza B and C have multiple lineage evolution, allowing the presence of co
circulating strains within human population (Yamashita et al., 1988).  Therefore, B
and C type influenza are approaching equilibrium with their human hosts but the type
A influenza viruses are being prevented by perturbations arising from the
reassortment of human virus genomes with those from avian viruses.
2.2.2 Antigenic Shift & Drift
Influenza is a difficult disease to prevent and contain because it is able to
disguise itself as a new agent, never seen before because it can mutate quickly and
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regularly produces new strains through antigenic drift and shift.  Antigenic drift is the
appearance of a virus with a slightly changed antigenic structure resulting from the
accumulation of point mutations of the viral surface proteins. The theory of antigenic
drift assumes new antigen sequences arise by natural selection of mutants in influenza
viruses.  The rate of the point mutations depends on the evolutionary rate and is
highest in human viruses (Reid et al., 2004).  These point mutations prevent
antibodies made after previous infections from binding to the surface HA properly in
order to destroy the virus.  Through these mutations influenza virus has enabled itself
to replicate without being destroyed by host defense mechanisms.
Antigenic shift is a major change in the surface of a virus when completely
new proteins are acquired through viral reassortment.  Reassortment occurs in one
cell, in a susceptible host with two different strains, either two avian or an avian and
human.  This new reassortant strain is unrelated to any previous strain circulating.
The human pandemics of 1957 and 1968 resulted from antigenic shift when avian
strains co circulating with the human strain reassorted creating a new virus for the
human population (Schafer et al., 1993).  These major antigenic shifts have common
characteristics; appearing suddenly and antigentically distinct from the current human
influenza viruses circulating.  There is ample confirmation for genetic reassortment
between human and avian viruses in vivo (Wilson et al., 1980) as well as reassortment
in humans (Cox, Bai, and Kendal, 1983).  The 1957 pandemic strain contained avian
HA, NA and PB1 genes combined with the circulating human H1N1 while the 1968
H3N2 contained HA and PB1 avian genes (Schafer et al., 1993).  Antigenic shift is
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capable of causing a pandemic at any time because there is no history of infection for
the subtype in the population and thus there is no immunity.
The direct transmission of avian H5N1 and H9N2 viruses to humans in
southeastern China and Hong Kong in 1997, 1999 and 2004-2005 have renewed
interest in the role of avian influenza virus zoonosis (Guan et al., 2000; Perez et al.,
2003a; Perez et al., 2003b).  These infections raise the possibility that a pandemic
influenza virus could arise from the direct transmission of an avian influenza virus to
humans.  The one barrier holding the current H5N1 from causing real trouble in Asia
and worldwide is the lack of successful human-to-human transmission.  If these avian
viruses are able to infect humans and establish an infection there is always a chance
for reassortment between this avian virus and a co-circulating human influenza virus,
thus creating a new virus that can easily transmit to humans.
2.3 Influenza Life Cycle
2.3.1 Myxoviruses
Influenza viruses are single stranded, negative-sense RNA viruses with a
segmented genome.  They belong to the family Orthomyxoviridae, which includes
four genera, the influenza A, B, C viruses and Thogotavirus.  Type B and C viruses
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are restricted to humans while type A viruses infect avian species and mammals such
as swine and humans. Thogotavirus include tick-transmitted orthomyxoviruses.
Influenza A has eight segments.  They are independently encapsidated by the
viral nucleoprotein (NP) and each segment is associated with a polymerase complex
composed of the PA, PB1 and PB2 genes.  The polymerase complex binds to the 3’
and 5’ ends of the vRNA and holds the ends together in a circular structure.  The
subviral particle consisting of the viral RNA, NP and polymerase complex is referred
to as the ribonucleoprotein (RNP) particle.  The NP protein is the major structural
protein that interacts with the RNA segments to form the RNP.  The NP binds to PB1,
M1 and PB2 directly (Portela and Digard, 2002).  The RNP particles are located
inside a layer of M1 protein that lines the viral lipid membrane. The lipid membrane
is derived from the plasma membrane of the infected host cell.  It becomes part of the
viral particle during the budding process.  Embedded in the viral membrane are three
proteins; two spike glycoproteins, the hemagglutinin (HA) and the neuraminidase
(NA), and a membrane-channel protein, M2 (Zebedee and Lamb, 1988).  The HA is a
trimer of identical subunits which provides the receptor-binding site and elicits
neutralizing antibodies (Wharton et al., 1989).  Cleavage of the HA into HA-1 and
HA-2 is essential for fusion and viral infectivity.  The NA is a tetramer of identical
subunits that contains the receptor destroying activity needed for release of the newly
formed virus from the surface of the infected cell (Colman et al., 1989).  M2 forms a
membrane channel allowing acidification of the virus interior while it passes through
the endosome after attachment and entry.  This acidification is believed necessary for
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the release of RNP into the cytoplasm for viral replication and host cell infection.
The two non-structural proteins, NS1 and NS2 are found in the infected cell while
NS2 is also located in the virion (Pinto, Holsinger, and Lamb, 1992; Sugrue and Hay,
1991).
2.3.2 Virus Entry
Influenza viruses bind to sialic acid residues present on cell surface
glycoproteins or glycolipids via the receptor-binding site in the distal tip of the HA
molecule.  Specificities for sialic acid linkage differs depending on specific residues
in the HA receptor-binding pocket.  The preference is between sialic acid linked to
galactose by α2, 6 or α2, 3-linkages (Matrosovich and Klenk, 2003).
Entry of the virus into the host cell is through receptor-mediated endocytosis,
historically referred to as viropexis (Figure 1).  The virus enters the cell in a clathrin
coat formed by invagination of specialized coated-pit domains of the host plasma
membrane.  After internalization the clathrin coat is removed and vesicles fuse with
endosomes, beginning with a primary endosome and increasing in acidity to end with
a late endosome.  The acidification occurs through H+-ATPases.  The viral RNPs pass
into the cytosol by crossing the membrane of the virion and endosome (Skehel and
Wiley, 2000; Stegmann, 2000).
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The HA mediates fusion of the viral membrane with the endosomal membrane
based on the pH of the transition of HA to its low pH form. When a virion particle
has been endocytosed the low pH activated ion channel of the virion-associated M2
protein allows the flow of ions from the endosome to the virion interior disrupting
protein-protein interactions and freeing the RNPs from the M1 protein (Colman and
Lawrence, 2003).  A possible additional role for the M2 protein in ion channel
activity is the preparation of HA for the fusion process (Bron et al., 1993).  Low
pathogenic viruses (LP) containing HA with a single positive charge at the cleavage
site are cleaved by specific enzymes such as tryptase Clarab present in lungs,
whereas HA containing multiple basic residues at the cleavage site are cleaved by
proteases such as furin and subtilism-type enzymes, present throughout the body
(Horimoto and Kawaoka, 1995; Kido et al., 1999).  Therefore, highly pathogenic
viruses (HP) can infect other tissues and spread throughout the host causing a
systemic infection.  Virus particles containing uncleaved HA can bind to and enter
host cells but do not undergo fusion and are therefore non-infectious (Colman and
Lawrence, 2003).  Once the M2 ion channel acidifies the internal virion core
releasing the vRNP from the M1 the vRNP moves to the cytoplasm.  This M1-free
vRNP is then imported into the nucleus through a nuclear pore using nuclear transport
signals of NP.  The M1 protein, which is dissociated from the RNP enters via active
transport, its size, 70kD, is larger than the maximum 40kD allowed for passive
diffusion (Neumann, Hughes, and Kawaoka, 2000).
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Transcription of the RNPs to mRNA occurs in the nucleus. Transcription and
replication are both catalyzed by the viral RNA-dependent RNA polymerase
complex.  The PB1 subunit of the polymerase complex has a major role in the
catalytic activity of the viral polymerase.  It contains the conserved motifs
characteristic of RNA-dependent RNA polymerases and RNA-dependent DNA
polymerases (Biswas and Nayak, 1994; Muller et al., 1994).  The PB2 is essential for
transcription (Kobayashi, Toyoda, and Ishihama, 1996).  It is responsible for the
recognition and binding of host mRNAs although the PB1 binds to the terminal
sequences of vRNA and cRNA and performs capped RNA endonuclease activities
(Li, Rao, and Krug, 2001; Ulmanen, Broni, and Krug, 1981).  PA is associated with
replication activity of the polymerase (Mahy et al., 1983; Perales et al., 2000).   PA is
associated with N-terminus of PB1 (Perez and Donis, 2001).  Optimal viral RNA
transcription and replication are dependent on the formation of the heterotrimer
(Honda et al., 1990; Huang, Palese, and Krystal, 1990).
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Figure 1.  Influenza Viral Attachment and Entry
Figure from http://www.agnr.umd.edu/avianflu
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2.3.3 Viral mRNA Synthesis
Viral mRNA synthesis occurs in the nucleus and requires initiation by host-
cell primers, in particular capped (m7GpppNm-containing) RNA fragments which are
derived from host-cell RNA polymerase II transcripts.  These host-cell primers are
generated in the nucleus through the action of a viral cap-dependent endonuclease.  A
5’-methylated cap structure is required for priming. Cap binding is performed by PB2
followed by capped RNA cleavage by PB1.  The endonuclease activity in PB1
cleaves mRNAs 10-13 nucleotides from their 5’ end, preferentially after a purine
residue (Braam, Ulmanen, and Krug, 1983).  Cap binding and cleavage are dependent
on the interaction of the polymerase complex with vRNA. PB2 binds to methylated
cap-1 structures at the 5’ terminal of the transcribed cellular mRNA and they are
subsequently cleaved by the P complex, producing 10 to 13-mers used for priming
viral mRNA transcription. Transcription is initiated by incorporating a G residue onto
the 3’ end of the fragments and viral mRNA chains are then elongated until the
polyadenylation signal, 5 to 7 uridine (U) residues, located 15 to 22 nucleotides
before the 5’ ends of the vRNAs.  Polyadenlyation occurs through reiterative copying
of the uridine sequence (Perez and Donis, 2001; Poon et al., 1999; Zheng et al.,
1999).
During transcription, the polymerase complex transcribes the negative sense
vRNAs into positive-sense mRNAs that are capped and polyadenylated. Viral RNP
complexes are formed for each of the eight segments.  Termination occurs from a
23
stuttering of the stretch of U residues, adding a poly(A) tail to the 3’ ends of the viral
mRNAs (Poon et al., 1999; Zheng et al., 1999).  In infected cells the vRNAs are both
transcribed into mRNAs and replicated.
  
The conserved 12 and 13 nucleotides at the 3’ and 5’ ends respectively are
shown below.  The U6 poly(A) signal near the 5’ end of the vRNA is separated by 2
or 3 segment specific residues from the conserved 13 nucleotides of the 5’ end.  The
cap structure and the 10-13 heterologous nucleotides at the 5’ end of the mRNA are
derived from the host cell pre-mRNAs.  The template RNA (cRNA) contains at its 5’
terminus a pppA and it is a complete copy of the vRNA segment.
5’AGCAAAAGCAGG---------AAAAAAN2-3CCUUGUUUCUACU 3’  cRNA
(template)
Replication
3’ UCGUUUUCGUCC---------UUUUUUN2-3GGAACAAAGAUGA 5’ vRNA
Transcription
5’ Cap-N10-13AGCAAAAGCAGG---AAAAAAAAAAn 3’         mRNA
5’ pppAGCGAAAGCAGG---------CCUUGUUUCUACU 3’       template RNA
2.3.4 vRNA Replication
Replication of vRNA occurs in two steps; the synthesis of template RNAs, the
full-length copies of the vRNA and the copying of template RNAs into vRNAs.
During replication a full-length copy of the vRNA, referred to as complimentary
RNA (cRNA) is synthesized and serves as the template for synthesizing progeny viral
RNA.  Replication is primer-independent.  The mechanism that triggers the switch
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from primer-dependent mRNA synthesis to primer-independent cRNA synthesis is
not well understood.  The production of cRNA is shown to require soluble NP
protein.  A possible role for NP is that it binds to the developing RNA transcript,
preventing the uridine stretch near the 5’ end of the vRNA from slipping backwards,
therefore preventing polyadenylation.  NP could also play a structural role, binding to
the cRNA and together with the viral polymerase complex prevent the degradation of
newly synthesized cRNA molecules by cellular nucleases (Honda et al., 1988; Huang,
Palese, and Krystal, 1990).
At the second step of replication, full-length anti-genomic cRNA serves as the
template for progeny vRNA synthesis.  vRNA synthesis, similar to cRNA, is primer-
independent, requires NP, and results in the full-length viral transcripts. The switch
from the synthesis of viral mRNAs to that of template RNAs requires that the capped
RNA-primed initiation change to unprimed initiation.  Because the switch calls for
protein synthesis, one or more newly synthesized virus-specific proteins are assumed
to be necessary for the unprimed synthesis and / or anti-termination at the poly(A)
site.  Thus, at least two polymerase complexes can be postulated to exist in infected
cells.  One, which is also present in the virion, uses capped primer fragments to
initiate mRNA synthesis, requiring PB2 protein, while the second type initiates
synthesis of either template RNA or vRNA chains without a primer, requiring NP
(Area et al., 2004).
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The production of viral proteins is regulated to the time they are required
during replication and in relation to the amounts of structural components necessary
for virion assembly.  Synthesis of the different viral proteins is proportional to the
amount of corresponding mRNAs.  There are two phases of gene expression, early
and late.  The early phase begins after primary transcription and corresponds to a
stage of vRNA replication and amplification of mRNA production.  During the early
phase synthesis of specific vRNAs, viral mRNAs and viral proteins are coupled.
After primary transcription, the first event to occur is template RNA synthesis.  The
rate of template RNA synthesis peaks early and declines sharply.  Specific template
RNAs are then transcribed into vRNAs.  Preferential synthesis of the NP and NS1
proteins occur in the early phase, the consequence of selective replication of the
vRNA templates from which their mRNAs are transcribed (Shapiro, Gurney, and
Krug, 1987; Skehel, 1972).  The production of NP and NS1 in early phase highlights
their role in the regulation of transcription and replication of vRNAs.
During the late phase, which focuses mainly on the production of virion
structural components, the vRNAs are synthesized in equal amounts, necessary for
the progeny genomes.  Synthesis of all viral mRNAs peak at the beginning of the late
phase but synthesis of the vRNAs remains high during the late phase.  Therefore
vRNA and viral mRNA are no longer coupled during this second phase.  Viral protein
production also remains high during the late phase, thus ending viral mRNA
synthesis.  Previously synthesized viral mRNAs direct the viral protein production
with a change in production preference.  Transcription is directed towards the HA and
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M1 proteins while NS1 production decreases.  The synthesis of all three virus-
specific RNAs occurs in the nucleus.  Template RNAs, synthesized at early phase
remain in the nucleus to direct vRNA synthesis throughout infection while the
vRNAs are transported to the cytoplasm at late phase.  M1 protein is thought to be
synthesized late because this protein stops transcription of vRNA into viral mRNA
and mediates transport of the vRNA, in the form of nucleocapsids, to the cytoplasm
(Marin et al., 1991).  Regulation of mRNA splicing is important in controlling the
ratio of full-length and spliced mRNAs for NS and M genes to produce NS1, NS2,
M1 and M2.  NS splicing into NS1 is regulated by cis-acting sequences in the NS1
mRNA while the production of M2 ion channel protein is controlled by viral and
cellular proteins.
2.3.5 Transport and Assembly
Virus integral membrane proteins HA, NA and M2 are synthesized on
membrane-bound ribosomes and are translocated across the endoplasmic reticulum
(ER) in a signal recognition particle (SRP)-dependent manner. Involvement with the
ER includes cleaving the N-terminal sequence of the HA by signal peptidase,
glycosylation of N-linked carbohydrate chains to NA and HA and trimming of
mannose-rich oligosaccharides.  After correct folding and assembly of the proteins
they are transported out of the ER to the Golgi apparatus where further processing of
oligosaccharides occur.  The M2 modifies the acidity of the trans Golgi network to
protect the HA from possible inactivation.  The integral membrane proteins are
transported to the plasma membrane where virion assembly and budding occurs.
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Both HA and NA have been shown to interact with lipid rafts (Hobman, 1993; Nayak
and Barman, 2002).  It is generally believed that viral glycoproteins determine the site
of virus assembly and budding.  This belief stemming from the fact that viral
glycoproteins accumulate at the site of virus budding even when expressed alone
(Hobman, 1993).  Viral glycoproteins may not be the only determinant for selecting
the site of virus budding, other viral components such as M1 and vRNP as well as
host components may be involved in determining the budding site (Nayak and Hui,
2004).  The RNP-M1 core acquires a membrane derived from the host cell plasma
membrane, an area modified to contain almost no host membrane proteins.  The PB1,
PB2, PA and NP genes of the transcription / replication complex each contain
karyophilic signals that direct the genes from their site of synthesis in the cytoplasm
to the nucleus where they assemble into functional complexes and nucleocapsids.
The polymerase complex associates with the termini of viral RNAs in RNPs.  The M1
present in the nucleus joins the vRNP and facilitates export from the nucleus and
prevents re-entry.  The NS2 protein, also called the nuclear export protein (NEP),
mediates export of the vRNPs by acting as an adaptor between the vRNP-M1
complex and nucleoporins of the nuclear export machinery.  Nucleocapsids are
exported out of the nucleus and progeny virus particles are packaged.  The action of
viral neuraminidase is necessary for the release of the effective virions.
Budding requires three additional steps; the selection of an assembly site
where viral components are transported and assembled to initiate the budding process,
growth of the bud and completion of the bud with release of the virus particle (Nayak
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and Hui, 2004).  Each step in the budding process is complex and not completely
understood but it is well accepted that it requires interaction and involvement of both
host and viral components.  Bud formation and release are the last steps in viral
replication and production of new infectious virions.
Pinching off of the virus buds require fusion of the opposing viral and cellular
membranes.  This leads to fission and separation of the bud from the cell (Nayak and
Hui, 2004).  M1 proteins have been shown to be the key component of bud formation
and pinching off (Nayak and Barman, 2002; Nayak and Hui, 2004).  Although M1
proteins alone can initiate and release virus buds for an influenza virus to be
infectious, all eight RNA segments are required.  It is not known if this mechanism is
selective or random.  There is evidence for both.   If the mechanism were random,
there would be common structural elements in all vRNPs, causing them to be
incorporated randomly.  Support for this model is the observation that influenza A
virions can have more than eight vRNPs (Bancroft and Parslow, 2002).  If the
mechanism is random, the probability of packaging eight segments into a virion
requires that only 12 segments need to be randomly packaged to have 10% of virions
containing one copy of each of the 8 segments (Enami et al., 1991).  If the mechanism
is specific, the structural feature in each vRNA segment enables them to be
selectively incorporated into virions.  Evidence for this model comes from studies
that show the various vRNAs are equimolar within viral particles although their
concentrations in infected cells may differ (Smith and Hay, 1982).  Viruses must be
released into the surrounding environment in order to infect other cells.  Bud
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formation and closure causing pinching off of the virion may not be sufficient to
release the virus into the external environment because the released virion may still
be attached to the infected host cell by sialic acid.  The enzymatic activity of the NA
removes sialic acid, the receptor for influenza, from the membrane glycolipids and
glycoproteins from both the virus particles and infected cells, preventing self
aggregation of virus particles and reattachment to the virus-infected cell (Liu et al.,
1995).
The site and nature of budding can be an important factor in viral
pathogenesis.  Influenza viruses that bud from the apical surface, typically from
polarized epithelial cells and into the lumen of the lung are restricted to the lungs and
do not cause viremia.  However some influenza viruses with the polybasic amino acid
cleavage site of HA (highly pathogenic influenza) are not restricted to the lungs and
thus produce viremia infecting other organs (pantropism) causing sever mortality to
the infected host (Liu et al., 1995; Mori et al., 1995; Subbarao and Katz, 2000). 
2.4 Host Range of Influenza
2.4.1 Molecular Determinants of Host-cell Restriction
Host range is a polygenic trait (Ito and Kawaoka, 2000). The hemagglutinin
(HA) subtype plays a major role in the host range and pathogenicity of each virus
subtype and strain.  Cleavability of the HA is an important determinant of virulence
but may not be for host range.  The mechanism by which certain HA subtypes infect
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and cause illness in mammals while other subtypes are unable is not well understood.
The receptor-specificity of influenza HA depends on the host species they evolved
from, the infections are dependent on interactions between the HA and cell
oligosaccharides that have sialic acid residues.  Avian viruses preferentially bind to
sialyloligosaccharides terminated by SAα2, 3Gal, where human viruses prefer SAα2,
6Gal conformation (Rogers and Paulson, 1983).  The binding preference appears to
be associated with the amino acid located at position 226 in the HA, Leu-226 in
humans and Gln-226 in avian viruses.  It is generally accepted that to change host
range influenza viruses need to override the selective binding.  A possible route is by
going through an intermediate host carrying both receptors, thus creating a new virus
through reassortment.  Swine have been suggested to have a role due to the fact that
they posses SAα2, 3Gal and SAα2, 6Gal (Ito et al., 1998; Scholtissek, Hinshaw, and
Olsen, 1998). There have been only a limited number of avian and human influenza
viruses that have established stable lineages in pigs (Makarova et al., 2003).  Recent
evidence introduces certain terrestrial poultry, such as chickens and quail, who
provide an environment similar to pigs (Gambaryan, Webster, and Matrosovich,
2002; Guan et al., 1999).  Such instances in 1997 with H5N1 and in 1999 with H9N2,
where avian viruses circulating in poultry in Hong Kong were transmitted to humans,
are scenarios that seem to be increasing in familiarity (Lin et al., 2000; Peiris et al.,
1999; Shortridge, 1999) .  There is no solid evidence for neuraminidase (NA) action
in host-range discrimination but changes to the NA gene can alter virulence properties
or the ability of the virus to form plaques in tissue culture (Schulman and Palese,
1977; Sugiura and Ueda, 1980).
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2.4.2 Interspecies Transmission
Influenza A viruses cross species barriers relatively easily and often. The
establishment of a stable lineage and the spread thereof is however a rare event.  For
the introduction of a foreign gene into a new genetic constellation by reassortment, an
adaptation must take place.  This adaptation must occur for optimal function of the
new gene within the framework of the available viral proteins.  Although aquatic
birds are the natural reservoir for influenza A viruses, the viruses from these birds
replicate poorly in mammals including humans (Hinshaw et al., 1980a; Hinshaw et
al., 1980b; Webster et al., 1978).  Therefore, viruses from aquatic species must
undergo some change before they can cross the species barrier.  Influenza viruses can
reassort because of their segmented genome.  Human influenza strains are thought to
be able to acquire genes from avian influenza viruses through this reassortment or
through an adaptation in an intermediate (Schafer et al., 1993).
Swine may be the mixing vessel for the reassortment of human and avian
influenza viruses.  Pigs have receptors in both the SAa2, 6Gal and SAa2, 3Gal
conformation and are susceptible to influenza viruses from both avian and human
sources (Kida et al., 1994).  Therefore the pig can reassort an avian and human virus
producing a new virus to which the human population is immune naive.  In areas of
Asia where backyard pigs co-mingle with chickens and even migratory ducks the
potential for reassortment is present.  The infrequent transmission of avian influenza
viruses to pigs may be the limiting factor in their role as intermediate hosts.  Studies
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have shown evidence that H3N2 human influenza virus variants can persist in pigs
after leaving the human population.  However, in nature, a limited number of human
and avian viruses have established stable lineages in swine and only occasional
transmission of influenza from pigs to humans, resulting in respiratory disease, has
been noted (Brown, 2000; Brown, Gajdusek, and Morris, 1966; Makarova et al.,
2003; Shortridge et al., 1977).
In 1997 in Hong Kong, H5N1 viruses, circulating in poultry were transmitted
to humans which caused 18 illnesses and led to 6 deaths (Shortridge, 1999).  Genetic
characterization of the isolates from humans and poultry in Hong Kong live bird
markets indicated that avian H9N2 and H6N1 viruses were co-circulating with the
avian H5N1 virus.  Both the H6N1 and H9N2 viruses are endemic in quail in Hong
Kong.  The H9N2 virus was first isolated in quail in 1988 and transmitted to humans
and swine by 1999 (Chin et al., 2002; Guan et al., 2000; Guan et al., 1999; Hoffmann
et al., 2000; Perez et al., 2003a).  In particular, A/Quail/HK/G1/97 (H9N2) is thought
to have been involved in the generation of the highly pathogenic H5N1 human virus
of 1997.  The six internal genes of this quail H9N2 as well as the human cases of
H9N2 infections were similar to the internal genes of the H5N1 viruses co-circulating
in poultry in 1997 and which caused fatal human infections. The H5N1 viruses were
reassortants that derived their internal genes from a Qa/HK/G1/97-like virus (Lin et
al., 2000; Makarova et al., 2003).  The antigenic differences between human and
swine H9N2 isolates show that swine viruses were not intermediates in avian to
human transmission indicating land-based poultry are a potential source of influenza
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viruses that can transmit to humans (Makarova et al., 2003; Shortridge et al., 1998;
Webby and Webster, 2001).  These avian H9N2 viruses have receptor specificity
similar to that of human H3N2 viruses providing evidence of a stable avian lineage
with human virus-like receptor specificity and the ability to infect different poultry
species including quail, chicken and pheasant.  This clearly shows that a strict
receptor-specificity, typical of influenza viruses in wild aquatic birds may not be an
absolute for replication in other avian species (Matrosovich et al., 2000).
Phylogenetic analysis of the H9N2 influenza viruses isolated in domestic ducks in
southern China during the 2000-2001 season indicate that the H9N2 virus lineage has
transmitted back to the ducks, creating double and sometimes triple reassortants with
viruses resident in the ducks (Li et al., 2003).  This creates a two-way transmission
between terrestrial and aquatic birds generating multiple genotypes of H9N2 viruses
containing internal genes of aquatic avian origin and more importantly creating a
virus with pandemic potential.
The human outbreak of H5N1 in Hong Kong in 1997 was proof that avian
viruses can transmit directly to humans.  Accordingly there has been an increase in
surveillance and characterization of influenza A viruses from quail in the region.
Outbreaks in quail have been few, the first reported in Italy between 1966-1968
(Nardelli et al., 1970).  Thirteen flocks of quail were found to be infected with an
influenza A virus that caused respiratory distress and was lethal to quail younger than
3 months (Makarova et al., 2003).  Influenza viruses of many subtypes have been
isolated in North America, Europe and Asia from quail including H5N2, H7N2,
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H7N3, H9N2 and H10N8 (Guan et al., 1999; Guo et al., 2000; Saito, Kawaoka, and
Webster, 1993; Suarez et al., 1999).
2.4.3 Quail as Potential Intermediate Hosts
Quail have been proposed to act as an intermediate host in the process of
transmitting avian viruses to humans.  The 1997 human outbreak of H5N1 supports a
convincing role that quail play in taking a mallard virus and adapting it, allowing
replication and transmission within quail and throughout species, particularly land
based birds.  Quail have been shown to be a reservoir for influenza viruses, creating
an environment for replication and transmission to other species.  The actual method
of how that transmission occurs is not well understood.  Quail infected with the
highly pathogenic A/Turkey/Ontario/7732/66 (H5N9) show no clinical symptoms but
can transmit the virus to chickens causing morbidity and mortality (Slemons and
Easterday, 1972; Tashiro, Reinacher, and Rott, 1987).  Quail are also more
susceptible to infection with goose H5N1 than chickens.  The virus replicates in the
respiratory tract of the quail and is transmitted by aerosol.  The virus has a longer
incubation in the quail than the chickens, displaying signs of disease and death later,
therefore increasing the likelihood of transmission.  Viruses like H5N1
A/Goose/Guangdong/1/96 (H5N1) circulating in 2003 in Southern China replicate in
the trachea of quail, transmitted by aerosol and are highly pathogenic in the quail
(Webster et al., 2002).
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In a study done by Perez et al. (2003) quail were infected with six H9N2
strains isolated from domestic ducks.  Quail were susceptible to infections with all six
viruses.  Replication was predominant in the respiratory tract with little to no virus
isolated in the fecal material.  This is noteworthy since waterfowl shed most of the
virus through the fecal-oral route (Webster et al., 1978).  The infection in the
respiratory tract promotes viral shedding in the aerosol, the same method of shedding
and transmission that occurs in mammals, particularly humans.  Thus influenza virus
infections in quail can promote a change in the tissue tropism of avian strains,
permitting the emergence of variants transmitted by aerosol (Perez et al., 2003a).
In contrast to the quail’s susceptibility, chickens inoculated with the duck
H9N2 viruses maintained infection in only 2 of the 6 viruses.  Therefore quail are
more susceptible to infection with H9N2 duck viruses than chickens, however,
transmission studies show additional adaptations are required for the virus to transmit
to uninfected quail.  Perez et al. (2003) looked at the possibility of a previously
adapted H9N2 quail virus transmitting to other species.  This quail-adapted virus,
A/Quail/Hong Kong/A28945/88 (H9N2), was able to transmit to other quail as well
as from quail to chickens, demonstrating that a quail-adapted virus is capable of
crossing the species barrier.
To understand the potential role played by quail in the live bird markets in
southern China as well as in other areas of the world, Makarova et al. (2003) infected
quail with all 15 hemagglutinin subtypes to see if each could establish an infection
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and if it could then transmit to other quail.  Viruses taken from North American and
Eurasian lineages confirm quail could establish infection in both lineages.  Quail
replicated 14 of the 15 subtypes, the exception being a mallard H15N8.  Replication
occurred in the respiratory tract, one virus, a shorebird H10N4, led to clinical
symptoms, killing 2 of the 6 quail infected.  Although quail can be experimentally
infected with 14 of the 15 HA subtypes, no virus was able to transmit to sentinel cage
mates.  Additional adaptation is required for adequate transmission among quail.
Live quail are no longer permitted in the live birds markets in Hong Kong.  Public
authorities suspect quail transmit influenza viruses to other birds (Makarova et al.,
2003). Unfortunately markets in Mainland China and parts of Europe and the United
States continue to house many species of poultry, aquatic and terrestrial including
quail, in one location.  A market in Nanchang, China was surveyed and labeled by
Liu and colleagues as an ideal environment for the maintenance and reassortment of
influenza viruses.  This surveillance highlights quail as susceptible to all virus
subtypes isolated in the market (Liu et al., 2003a; Liu et al., 2003b; Makarova et al.,
2003).
Human influenza virus has been isolated in the trachea of one quail (Liu et al.,
2003a).  In experimental infections with human H1N1 and H3N2 viruses, quail have
limited replication and replication is highly unlikely to occur in nature, without prior
molecular modification (Makarova et al., 2003).  In contrast to the human viruses,
swine influenza viruses (H1N1, H3N2, H1N2) replicate in quail, although
inefficiently, the location is in the respiratory tract.
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The host range of influenza A viruses is polygenic, determined by surface and
internal gene products (Ito and Kawaoka, 2000).    Interspecies transmission of
influenza A viruses among non-natural hosts, in particular land-based birds, and the
factors that determine host range are not clear.  This project sets out to define changes
at the molecular level that determine adaptation of mallard viruses in quail and what
changes are necessary for the transmission to other species, in particular chickens.
This research project determined the ability of an aquatic avian influenza
virus, A/Mallard/Potsdam/178-4/83 (H2N2), to replicate and transmit in quail.
Influenza viruses of the H2 cause the Asian pandemic of 1957 and then disappeared
from the human population 11 years later.  The pandemic resulted from a reassortant
of the circulating human H1N1 and avian H2N2, most closely related to the Eurasian
avian H2 HAs (Schafer et al., 1993).  The new virus contained avian HA, NA and
PB1 genes (Kawaoka, Krauss, and Webster, 1989; Scholtissek et al., 1978).  Avian
H2N2 isolates were first noted in 1972 and surveillance of avian influenza and strain
isolation was not set in motion until 1970.  This H2N2 subtype continues to circulate
in avian species.  It has been almost 40 years since it has last circulated in humans,
resulting in a population whose majority is immune naive and / or lacks the memory
B cell response to battle this potential pandemic reemergence (Govorkova et al.,
1993).  H2 influenza disappeared from the human population in 1968 with the
emergence of the H3N2 strain and pandemic, but H2N2 influenza viruses have been
isolated from domestic and wild birds in recent years.  Avian H2 influenza viruses are
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divided into two distinct lineages, based on geography, North American and Eurasian
(Liu et al., 2004).  There was an increased prevalence of H2 influenza in wild ducks
in 1988 in North America leading to the appearance of H2N2 in domestic fowl
(Schafer et al., 1993).  Antigenic analysis indicates that the majority of avian H2N2
isolates from wild birds up through 1991 are closely related to the early human H2N2
viruses, demonstrating that H2N2 pandemic-like virus strains are continually
circulating.  Antigenically distinct H2N2 viruses have been isolated from shorebirds
in Delaware in 1993 and 1997.  The H2 HA genes of the Eurasian lineage were
transmitted to North American birds, however no internal genes have been reported in
the North American lineages (Makarova et al., 1999; Schafer et al., 1993).  In
contrast, Eurasian strains can gain the internal genes from the North American
lineage, proving interregional transmission of the internal protein genes of influenza
occur between North American and Eurasian migratory ducks (Liu et al., 2004).  As
the prevalence of avian H2N2 influenza viruses increase, greater numbers come into
direct contact with susceptible humans, highlighting the importance of surveillance
and characterization of H2 influenza viruses in wild and domestic avian species.
Though no H2 viruses have been isolated from swine, transmission of
influenza from bird to human has occurred (Claas et al., 1998; Subbarao et al., 1998;
van Kolfschooten, 2003).  In 1997 and 1999, human infections with H5N1 and H9N2
strains respectively (Shortridge, 1999) have resulted from direct transmission by land-
based birds, indicating their possible role as a vehicle capable of crossing the species
barrier.  Quail are a member of that group.  Our goal is to determine how much
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change is needed to adapt a strain, from its natural reservoir, to a species that can
transmit within its species and across to other species, including mammals.
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CHAPTER 3, MATERIALS AND METHODS
3.1 Influenza Virus
The H2N2 virus, A/Mallard/Potsdam/178-4/83, was provided by the
repository at St. Jude Children’s Research Hospital, Memphis, Tennessee.  The virus
was propagated in 10-day-old embryonated SPF chicken eggs and stored at –700C.
The virus was titrated to determine the egg infectious dose 50 by the Reed and
Muench method (1938). The stock virus yielded a concentration of 5 x 107 EID50 / ml
when titrated in eggs.  Hemagglutinin Assay revealed a titer of 1:1024.
3.2 Animals and experimental infections
Four to six-week old Japanese quail (Coturnix coturnix) (Department of
Animal and Avian Sciences, University of Maryland, College Park), three to four-
week White Leghorn chickens (Charles River Laboratories, Wilmington, MA) and
two to three-week old mallard ducks (McMurray Hatchery, Webster City, IA) were
used.  Birds were fed Purina Mills game bird diet and food and water was provided
ad lib for all studies.
Virus was administered in doses of 600 µl at a concentration of 5 x 106 EID50/
ml.  Infection routes were through the nares, mouth and eyes with roughly 100 µl
given through the nares and eyes and the remaining 500 µl through the trachea.
Feeding gavages were used to administer the virus.  The inoculum was prepared in a
10-fold dilution using a solution of PBS with 1% antibiotic/ antimycotics (100X
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Sigma).  Tracheal swabs were collected days 1, 3, 5, 7, 9 post-infection and stored in
glass vials containing 1 ml glycerol medium at –700C (50% sterile glycerol, 50%
PBS, 1 ml/ 200 ml total volume gentamicin, 10 ml 100X antibiotic/antimycotics)
(Guan et al., 2000).  Swab samples were tested for virus by passing swab medium in
10-day-old embryonated chicken eggs (Palmer et al., 1975).  Three eggs were used
for each swab collected and 200 µl of medium was injected into each egg, incubated
for 48 hours and chilled at 40C for no more than 24 hours, or 30-60 minutes at –200C.
Allantoic fluid was collected and a hemagglutinin assay was performed to determine
virus presence.  Samples showing agglutination were scored as positive.
Clinical symptoms that are usually associated with influenza infections in
poultry include ruffled feathers, excess mucous, cyanosis (usually on the tongue),
appetite and weight loss and a drop in egg production.  None of the females in any of
the passages in this experiment were at sexually maturity.  Additional symptoms are
listed in Table 1. Birds were observed and scored daily for clinical signs of illness and
general well being.  Animals were evaluated on appetite, activity, fecal output and
signs of distress or clinical illness including cyanosis of tongue or legs, ruffled
feathers and respiratory distress.  Birds were scored on a scale of 1 to 4, 4 requiring
euthanasia.  Table 2 lists the categories each symptom was grouped into and the
appropriate score associated with the symptom.
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Experiments were carried out under BSL2 conditions with investigators
wearing appropriate protective equipment and compliant with all IACUC approved
protocols (R-03-13) and under AWA regulations.
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Table 1 Infection Study Endpoints
Infection Study Endpoints: Clinical Signs associated with influenza infection in
poultry
Typical of low pathogenic avian influenza
 Ruffled feathers
 Depression and lethargy
 Loss of appetite / weight loss
 Respiratory distress
 Diarrhea
Typical of high pathogenic avian influenza
  Cyanosis (purple-blue coloring) of wattles and comb and tongue Edema and
swelling of head, eyelids, comb, wattles, and hocks
 Blood-tinged discharge from nostrils
 Incoordination, including loss of ability to walk and stand
 Pin-point hemorrhages (most easily seen on the feet and shanks)
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Table 2, Score Table for Daily Observations in Poultry
Scores and Endpoints
Category of Clinical Symptoms
Score/Endpoints 1) Ruffled feathers,
depression, loss of
appetite/weight loss,
respiratory distress.
2) Diarrhea,
cyanosis of
tongue, pinpoint
hemorrhages.
3) Edema and swelling
of head, eyelids, legs,
blood-tinged discharge
from nostrils,
incoordination.
Score
1- 1 or 2 clinical symptoms; from category 1
2- 3 or 4 clinical symptoms; from category 1
3- 5 or 6 clinical symptoms; from combination of categories 1 and 2
4- 7 clinical symptoms; from combination of categories 1, 2, and 3 (if the bird
does not appear to recover at the beginning of the 3rd day, it will be
euthanized).
Table 2. Birds were observed and scored daily for clinical signs of illness and general
well being.  Animals were evaluated on appetite, activity, fecal output and signs of
distress or clinical illness, including cyanosis of tongue or legs, ruffled feathers and
respiratory distress.  Birds were scored on a scale of 1 to 4, 4 requiring euthanasia.
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3.3 Transmission of influenza virus in quail
            For transmission experiments, three quail, four to six weeks old, were infected
with virus at a concentration of 5 x 106 EID50 / ml, and volume of 600 µl, as
previously described.  Three contact quail were introduced at day one post-infection,
into the cage with the infected quail.  Water and food bowls as well as cage liners
were changed in order to prevent transmission of virus via contaminated water or
food.  Therefore, if transmission occurred it was through direct contact with the quail
and not because of virus contamination.  Tracheal samples were collected day 1, 3, 5,
7, and 9 post infection and HA assays were run to determine viral shedding.
3.4 Adaptation if mallard H2N2 virus in quail
Adaptation experiments comprised of eight passages of
A/Mallard/Potsdam/178-4/83 (H2N2) virus in quail.  The first five passages consisted
of three quail that were infected with a 600 µl dose of virus.  The remaining three
passages were groups of six quail and transmission studies were carried out.  The first
passage’s dose was H2N2 viral stock (wild type) grown once in embryonated chicken
eggs, as described above.  Later passages were inoculated with either a 10% lung
homogenate from the previous passage, a two-fold dilution of swab medium using
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PBS/ antibiotic/antimycotic (abbreviated PBS/Antb) or a ten-fold dilution of allantoic
fluid, collected from swab inoculation, into PBS/Antb from the previous passage.
Tracheal swabs were collected on days 1, 3, 5, 7 post-infection and virus was detected
through HA assays as outlined in Table 3.
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Table 3, Dosing for Adaptation Study
Passage            Dose                        Swab Collected    Lung Homogenate Collected
                                                                                                Days                Days     
1   1:10 dilution stock virus    3 3
2   1:10 dilution afa from lung homogenate, p1b    3 3
3   10% lung homogenate pooled from p2    3 3
4   10% lung homogenate pooled from p3    1,3,5 5
5   10% lung homogenate pooled from p4    1,3,5 5
6c pooled swab medium, day 5, p5    1,3,5,7 7
7   1:10 dilution af from swabs, day 5, p6 contacts 1,3,5,7 7
8   1:10 dilution af from swabs, day 5, p7 contacts  1,3,5,7 7
a: af = allantoic fluid
b: p1-7 = passage 1, 2, 3, 4, 5, 6, 7
c: Transmission tested and confirmed
Table 3.  Doses were given to quail in 600 µl volumes.  Lung homogenate was
pooled, 1 ml from each quail, and used as the dose for the following group.  Tracheal
swabs were passed in embryonated eggs and allantoic fluid was collected and used
for doses in passages 7 and 8 because swab medium was directly used for PCR and
analysis.  Transmission was tested and confirmed at passage 6, this passage was
repeated three times before proceeding to passage 7 to ensure and confirm
transmission.
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3.5 Dose Preparations
Lungs were collected on day 3, 5 or 7 post-infection, as outlined in Table 3.3.
B-Euthanasia solution was administered intra-cardiac, 500 µl per quail.
Lungs were collected through the back of the quail.  A midline incision was made
from the neck to pelvic bones using a scalpel (Feather No10) and scissors were used
to cut through the rib cage to expose the lungs.  Each lobe was removed with forceps
and washed two times in PBS.  Lungs were then placed in tissue bags and weighed,
PBS was then added 1X to lung weight.  Lung tissue was homogenized using a
stomacher (80 Biomaster, Wolf Laboratories Limited, UK).  Lung tissue was
completely homogenized for the next passage’s dose.
A 10% lung homogenate was prepared by adding 10 ml of PBS to each tissue
sample and then filtered through a 0.22 µm filter unit (Corning #430626) and double
filter pad.  The next passage was infected with the 10% lung homogenate; 1 ml from
each quail was combined and used for dosing the next passage.  Doses of 600 µl were
administered, using sterile feeding gavages (Fisher Ref 7905,18x2” (50.8MM W/2-
1/4). Roughly 100 µl was given in the eyes and nares while the remaining 500 µl was
inoculated in the trachea.  Homogenate from each quail was titrated separately in
embryonated chicken eggs to confirm virus presence in each of the homogenate
doses.
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Preparations of swab medium were diluted two-fold in PBS/Antibiotics to
yield the dose for passage 6.  The medium was diluted to decrease the viscosity of the
glycerol-based medium and to ease administration in quail.  Allantoic fluid, used for
infections in passages 7 and 8, was diluted in a 1:10 dilution of allantoic fluid with
PBS/Antibiotic.  The allantoic fluid was from tracheal swabs from passage 6 contact
quail collected on day 5 post-infection.
3.6 Location of virus replication and shedding of WT and Quail-adapted H2N2
To confirm previous findings that quail replicate virus mainly in the trachea
and shed via aerosol in contrast to the fecal-oral route established in wild aquatic
birds (Makarova et al., 2003), both WT H2N2 and Quail-adapted H2N2 were
administered to quail in order to identify the location of maximum shedding and
replication.  Quail were divided into groups of six, three infected and three contact,
per virus.  Each viral group was infected and monitored as described for the
transmission and adaptation studies.  Tracheal and cloacal swabs were collected day
1, 3, 5 and 7 post-infection.  Swabs were passed in embryonated chicken eggs and
HA assays were run to determine if WT and / or Quail-adapted virus shed in the
cloaca as well as the trachea.
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3.7 RT-PCR and sequencing
Viral RNA was extracted from allantoic fluid or swab medium using the
RNeasy Mini Kit (Qiagen Sciences, MD) as directed by the manufacturer’s protocol.
RNA extraction, cDNA synthesis and RT-PCR amplification were performed as
described by Hoffman (et al).  Modifications were made when extracting RNA from
swab medium.  Briefly, 500 µl of swab medium was combined with 500 µl Buffer
RLT/BME and 500 µl 70% ethanol and the remaining protocol was followed.  For
cDNA synthesis, 8 µl of swab-extracted RNA was used rather than the usual 4 µl
when using allantoic fluid.  Sequencing was performed using the BigDye-Terminator
protocol V3.1 (Applied Biosystems, Foster City, CA).  Minor modifications were
made to the manufacturer’s protocol.  BigDye terminator solution volumes were
decreased so that Sequence RR-100 was at 2 µl and the 5X Sequence Buffer was a 3
µl per reaction.  To counter the change in volume Millipore water added was 10.5 µl,
DNA was 3 µl and primer (40 ng/ µl) was 1.5 µl to bring the total volume to 20 µl.
The PCR program was 96oC for 4 min, (95oC for 30 sec, 56oC for 10 sec, 60oC for 4
min) x 45 cycles, 40C forever.  In addition to the universal primers described by
Hoffmann, specific primers were designed and are listed in Table 4 (Hoffmann et al.,
2001).  Primers were designed through the alignment and analysis of sequences found
on the Influenza Database website, http://www.flu.lanl.gov.
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To sequence the quail-adapted virus, tracheal swabs from passage 5 were
grown in embryonated chicken eggs, titrated, aliquoted and stored at -700C for stock.
Passage 5 was chosen because it was the first to be used as the dose in the
transmission study.
52
Table 4, Primers designed for sequencing WT H2N2 and Quail-adapted H2N2
viruses
GENE                                           PRIMER 5’ to 3’ DIRECTION_____
HA
H2 362-386F CCAGGCAGTTTCAATGATTATGAAG
H2 386-362R CTTCATAATCATTGAAACTGCCTGG
H2 753-771F GAGGTAGAATGGAATTCTC
H2 771-753R GAGAATTCCATTCTACCTC
H2 1006-990R TTTTACATATTTGGGGC
H2 1260-1283F TTGGAAAAGAATTCAGTAACTTGG
H2 1473-1496F GTTTTGAATTTTATCACAAATGTG
H2 1773-1753R AGTAGAAACAAGGGTGTTTTT
NA
N2 342-324R AAAGCCGAATTGAATTGTCC
N2 845-867F GAGGAATGTTCCTGTTATCCTCG
N2 977-999F GGGCTCGTTGGTGATACACCCAG
N2 1283-1303F TTTATGTGGAGTTGATAAGGG
N2 1467-1445R AGTAGAAACAAGGAGTTTTTTTC
M
M 431-410R CCCATCCTGTTGTATATGAGAC
M 468-490F TGTGCCACTTGTGAGCAGATTGC
M 758-727R TGGTAGGCCTGCAAATTTTCAA
M 827-858F TGATATTGTGGATTCTTGATCG
NP
NP 431-412R GCGTCTTCTCCATTGTTCGC
NP 529-551F AGAATGTGCTCTCTGATGCAAGG
NP 716-697R TTGCACATTCTCTCATATGC
NP 856-878F GCCCATAAGTCCTGCTTGCCTGC
NP 1052-1031R GCAGAGTGGCAGCCATCCATA
NP 1360-1380F GACATGAGGACTGAAATCATA
PA
PA 336-317R CTTGGGCTTCTCAACCCCCG
PA 605-623F CCGAAAGAGGCGAAGAGAC
PA 728-709R CCATCCACATAGGCTCTAAA
PA 734-756F AACCGAACGGCTGCATTGAGGGC
PA 1321-1340F GCCCCAATTGAGCATATTGC
PA 1440-1420R TTATGTACACTCCCTTCATTA
PA 1861-1840R CAAAGAATTCTTTGGTCATGTC
PA 2039-2969F TTAGGGACAACCTGGAACCTGG
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GENE                                       PRIMER 5’ to 3’ DIRECTION______
PB1
PB1 419-400R GTCCAGTCATAGGTCTGGCG
PB1 742-764F GCAATTGCAACACCCGGAATGCA
PB1 960-940R ATTCTCATTCCATTTGGTGTT
PB1 1240-1259F GGAATGATGATGGGCATGTT
PB1 1360-1337R CATCAGAGGATTGGAGTCCGTCCC
PB1 1642-1664F GGACCAGCAACAGCTCAGATGGC
PB1 1811-1790R GGTCCTCCATCTGAAACCAACA
PB1 1930-1952F GAAATTGAGTCCGTAAACAATGC
PB2
PB2 412-392R CCATGTTTCAACCTTTCAACC
PB2 680-658R CGAACCAGTTCTCTTTCCAACAT
PB2 879-900F GCCATAGCACACAAATTGGCGG
PB2 900-879R CCGCCAATTTGTGTGCTATGGC
PB2 1012-1034F AGCTTTGGAGGCTTCACTTTCAA
PB2 1262-1242R TCTTGTGAGAACACCATTGC
PB2 1430-1452F TATTACCTGACATGACTCCCAGC
PB2 1774-1756R CAAACTCCATCTTATTGTA
PB2 1972-1994F GGAATGAGAATACTCGTAAGGGG
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3.8 Hemagglutinin Assays
Hemagglutinin assays  (HA) were performed for virus detection in swabs and
lung homogenate. 10-day-old embryonated chicken eggs (B&E Eggs, Your Springs,
PA) were inoculated with swab medium or lung homogenates (200 µl/egg) as
previously described  (Palmer et al., 1975).  Positive and negative controls used were
stock virus and PBS or uninfected allantoic fluid, respectively (Reed and Muench,
1938).
For titration of virus using lung homogenate or swab medium, serial dilutions
with PBS/Antibiotics were prepared, 10-1 to 10-5, and inoculated in eggs.  Egg
Infectious Dose (EID50) was also determined through HA assays of swab samples,
passed once in eggs, and used to compare concentrations of virus in wild type and
adapted studies using both Japanese quail and White Leghorn chickens (Palmer et al.,
1975).
3.9 Transmission of quail-adapted virus in chickens
After adapting the wild type H2N2 (WT H2N2) virus in quail, it was
necessary to determine if that adaptation would allow the replication of the virus to
other terrestrial birds, particularly chickens.  White leghorn chickens, three to four-
weeks of age, were used to test whether WT H2N2 or Quail-adapted H2N2 replicated
and transmitted in chickens.
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The chickens were inoculated with either WT or Quail-adapted virus.  Three
chickens were infected for each group and housed in separate BSL2 rooms.  Doses
were administered in the same manner as the quail although the doses were increased
for the chickens to a volume of 1 ml.  For the WT infection, viral dose was prepared
from wild type stock at a 1:10 dilution in PBS/Antb.  Therefore the chickens received
the same amount of virus, 5x106 /ml, as the quail.  In the Quail-adapted group, virus
was grown in embryonated chicken eggs from the tracheal swabs from quail in
passage 5 and then diluted in 1:10 ratio with PBS/Antb.  Viral titer from passage 5
stock was 2x109 EID50 / ml so the dose given was diluted and prepared at 5 x10
6
EID50 / ml.   To inocluate the chickens with virus, feeding gavages were used in the
same manner as the quail.  Drops were placed in the eyes and nares and the remaining
volume, roughly 600 µl was administered through the trachea.
One-day post infection three contact chickens were introduced into each
group.  Feeders and water containers were cleaned and disinfected to prevent
transmission to contacts through contaminated food and water.  Cloacal and tracheal
swabs were collected for the chickens.  Adaptation studies with the quail created a
virus that replicated and transmitted in the trachea of the quail, so to cover both areas
of possible shedding, tracheal and cloacal swabs were taken.  Swabs were collected
days 1, 3, 5, 7, 9, 11 and 15 post-infection.  Swabs were stored in the same conditions
as quail tracheal swabs, 1 ml glycerol medium at –700C (Guan et al., 2000).
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Daily observations were made for both groups.  The chickens in the wild type
and those in the Quail-adapted group were treated and observed in the same way.
Transmission studies for the WT and Quail-adapted viruses were repeated twice in
chickens as they were for the quail studies.  Therefore, the experiment was carried out
identically, in full three times to confirm all results and observations.
3.10 Weight Study
Clinical symptoms can be one indication of an influenza infection but when
signs are not apparent other measures can be taken to monitor the stability of the bird.
In addition to confirming transmission studies in both quail and chickens, the birds
were weighed and monitored during the study to see if through the life of the
infection quail and / or chickens lost weight in either of the viral groups.  Quail and
chickens were swabbed and weighed for 9 days.
3.11 Infectious Dose 50 Studies
To determine the dose that will infect half the quail, serial dilutions of the WT
and Quail-adapted H2N2 were prepared.  The dose for each virus in transmission
studies of WT H2N2 was 5x106 EID50/ ml; therefore dilutions of 5x10
5 to
50 EID50 / ml were prepared.  Stock was diluted with PBS/Antb.  Quail were assigned
three to a viral dilution and placed in cages separate from other dilution groups.
Tracheal swabs were collected on days 1 and 3 post-infection and HA assays were
run to detect viral shedding.  The dilution resulting in infection and shedding from
half the quail in the group was selected as the Quail-ID50.  For the Quail-adapted virus
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the dose at infection was 5 x106 EID50 / ml.  Dilutions prepared for the study ranged
from 5 x 104 to 5 x10-1 EID50 / ml.  Quail were again grouped in three per dilution
with ample space between cages to prevent transmission between dilution groups.
Tracheal swabs were collected on days 1 and 3 and tested for virus through HA
assays.
Chicken infectious dose 50 was performed for the WT H2N2 and the Quail-
adapted H2N2.  WT H2N2 was prepared in serial dilutions of 5x107 to
5x106  EID50 / ml.  Quail-adapted virus was prepared in dilutions ranging from 5 x10
6
to 5 EID50 / ml.  Chickens were observed for 5 days and cloacal swabs were collected
day 1 and 3 post-infection.
3.12 Replication in Mallard Ducks
Once A/Mallard/Potsdam/178-4/83 (H2N2) had been adapted in quail and
tested in chickens it was examined to see if the adaptation in quail led to a virus that
replicated and transmitted successfully in mallard ducks.  Two week-old mallard
ducks were used to test WT H2N2 against Quail-adapted H2N2 to see if any changes
in replication and shedding occurred.  Ducks were infected in the same manner and
with the same volume doses as the chickens and swab samples were collected from
the trachea and cloaca of the ducks.  Ducks were swabbed days 1, 3 and 5 post-
infection.  The objective of this experiment was to see whether adaptation of a
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mallard strain in quail could lead to a virus that would still be able to replicate and
infect the natural host.
3.13 Plaque Assays
Plaque assays were performed on select passages to compare plaque size and
number.  Three passages were chosen, Passages 1, 5 and 8 and were compared to
viral stock.  The assay dilutions from swab medium were 10-1 to 10-6 while allantoic
fluid from stock was diluted 10-4 to 10-9, based on the amount of virus in a swab
sample versus allantoic fluid.  Confluent MDCK cell monolayers in 6-well plates
were infected with 10-fold dilutions of virus in a total volume of 1 ml PBS at  40C for
15 minutes and then 45 minutes at 370C.  Cells were washed twice with PBS and
covered with an overlay of MEM containing 1.8% agar, 0.02% BSA, 1% glutamine
and 1 µg/ml TPCK trypsin.  After three days of incubation at 370C under 5% CO2, the
overlay was removed and cells were stained with 0.1% crystal violet in a 10%
formaldehyde solution.
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CHAPTER 4, RESULTS
4.1 Transmission of A/Mallard/Potsdam/178-4/83 (H2N2), in Quail
To determine if quail can replicate and transmit A/Mallard/Potsdam/178-4/83
a transmission experiment was performed.  As shown in Table 5, there was no
transmission of the H2N2 virus to contact quail.  Viral replication occurred in the
trachea of the infected birds to titers of 5x104 EID50 / ml.  Viral shedding peaked at
day 3 post-infection and virus undetectable by day 5.  There were no clinical
symptoms observed in any of the quail.  Quail gained weight by the end of the study.
4.2 Adaptation of A/Mallard/Potsdam/178-4/83 (H2N2) in Quail
The inability of the virus to transmit to sentinel quail was the basis for further
experiments.  Virus shedding peaked on day 3 post-infection with a titer of
5 x104 EID50 / ml for the quail infected with WT H2N2.  In order to adapt this virus,
lungs were collected from quail infected with the WT H2N2 and serially passed to
groups of three quail.  Swabs were collected from the trachea and at the day of peak
viral shedding, lungs were collected and homogenated.  Eight passages of quail were
involved in this adaptation study.  Table 3 in chapter 3, lists the doses administered to
each passage of quail involved in the adaptation study.  Table 6 highlights the
shedding of virus, days of lung collection and viral detection in the lung homogenate
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for passages 1 through 8.   At passage 6, transmission was tested and confirmed.
Table 5 shows transmission in contacts on day 3 post-infection.  Quail shed this virus
longer than previous passages.  Transmission occurred between day 2 and 3 post-
infection in 70% of the contacts and by day 5 in the remaining quail.   As with the
WT H2N2 infections, no clinical signs of illness or distress were noted in any of the
quail.
Passage 6 was repeated two additional times and transmission was confirmed
yielding the same results (Table 5).  Lungs were collected and tested from passage 6
for virus, however once transmission occurred, swab medium was used to dose the
next two passages.  Swabs from passage 6, day 5, contacts were used for PCR as well
as HA assays.  Therefore, allantoic fluid collected from the HA assays on contact
quail, on day 5 were used to infect passages 7 and 8.  Transmission was tested and
observed in passages 7 and 8.  Thus, a constant addition of sentinel quail every few
days would ensure viral success.
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Table 5, Transmission of WT H2N2 and Quail-adapted Virus in Quail
Transmission Study     Group          Day (number of positive swab samples)
                                                                        1          3          5          7          9          11
WT H2N2
Infected Quail 9/9 6/9 0/9 0/9 0/9
Contact Quail 0/9 0/9 0/9 0/9 0/9
Passage 6 H2N2
Quail-adapted Infected Quail 8/9 9/9 9/9 0/9 0/9
Contact Quail 0/9 7/9 9/9 3/9 0/9
Passage 8 H2N2
Quail-adapted Infected Quail 3/3 3/3 3/3 0/3 0/3 0/3
Contact Quail 0/3 0/3 3/3 3/3 2/3 0/3
Table 5.  Transmission studies of quail inoculated with the WT H2N2 virus and the
same H2N2 virus serially passed through six groups of quail. Tracheal swabs
collected days 1, 3, 5, 7 and 9 post infection show that A/Mallard/Potsdam/178-4/83
(H2N2) does not transmit to contact quail.  Quail infected with virus shed for 3 to 4
days with peak titers on day 3. WT H2N2 was then serially passed in quail.  Lungs
were collected and a 10% homogenate was prepared to use as a dose for the following
group of quail.  After five passages, the sixth group was tested for transmission and
transmission of the virus to contact quail was confirmed.  After transmission at
passage 6, the virus continued to adapt to the quail, improving the length of shedding
of the virus in contact quail. In neither the WT nor Quail-adapted studies did quail
show any clinical signs of infection.   Transmission experiments were run at three
separate times to confirm results.
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Table 6, Viral Shedding in Quail, Passages 1-8
Passage            Swab Collection                                              Lung Collection          
                        Day (positive out of 3)                                    Day (positive out of 3)
                        1          3          5          7          9          11        3          5          7          9
1 3/3 3/3 3/3
2 3/3 3/3 3/3
3 3/3 3/3 3/3
4 3/3 3/3 2/2 1/2*
5 3/3 3/3 3/3 2/3
6 8/18 16/18 18/18 6/18 0/18 1/3
7 3/6 6/6 6/6 3/6 1/6 3/3
8 3/6 3/6 6/6 3/6 2/6 0/6 1/3
• One quail from passage 4 was euthanized due to pecking from cage mates
• Bold numbers include contact quail
Table 6.  Tracheal swabs were collected and tested for virus shedding for each
passage.  At passage 4 shedding was observed at day 5 and tracheal swabs collected.
Lungs were then collected on day 5 for passages 4 and 5.  At transmission for passage
6, contact quail shed virus until day 7.  Contact shedding extended to day 9 post-
infection for passages 7 and 8.
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4.3 Location of viral replication and shedding
To confirm the location of viral shedding both WT and Quail-adapted viruses
were tested.  Cloacal and tracheal swabs were collected and HA assays were run to
determine viral presence.  As anticipated, quail did not successfully shed WT or
Quail-adapted virus via the fecal-oral route.  Out of 24 quail tested (groups of 6
quail/virus repeated twice each) only one quail shed virus via the cloaca.  This quail
was a contact quail in the quail-adapted virus group and the only positive cloacal
swab taken from this quail occurred on day 5.  Viral shedding correlated to previous
transmission studies, with the WT group shedding virus until day 3 post-infection
without transmission and the Quail-adapted virus shedding until day 7 in contacts and
day 5 in infected birds.
4.4 Adaptation of mallard influenza virus creates a strain capable of
transmitting to other terrestrial avian species
Quail’s role as an intermediate host in which an influenza virus can change its
phenotypic characteristics and increase its host range was investigated.   
White Leghorn chickens were chosen to test whether the newly quail-adapted
virus could lead to infection and transmission in chickens.  The WT,
A/Mallard/Potsdam/178-4/83 (H2N2) was also tested to compare infectivity and
transmissibility with the quail-adapted virus.
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Chickens infected with the WT H2N2 virus did not establish an infection in
the trachea or cloaca.  No virus was detected in either swab sample from infected
chickens and thus no transmission was noted in contact chickens from the WT group.
In contrast, chickens infected with the quail-adapted H2N2 shed virus, transmitted to
contact chickens and established an infection.  Infected and contact chickens
displayed clinical symptoms including lethargy, excess mucous and diarrhea.
Infected chickens shed virus up to day 9 while contact chickens began shedding virus
on day 3 post-infection and shed up until day 15.  All positive samples were detected
through cloacal swabs, no tracheal swabs were positive for virus in either group,
Table 7.
Quail-adapted A/Mallard/Potsdam/178-4/83 (H2N2) did not loose its ability to
replicate in mallard ducks.  Table 8 lists the days of shedding in both WT and quail-
adapted groups.  Adaptation of the mallard virus in quail led to a virus that shed in the
cloaca and trachea of mallard ducks, albeit less than the WT H2N2.   Ducks from
both groups showed no signs of infection.
Viral titers were measured in swabs collected from both infected and contact
quail, chickens and mallard ducks to determine if the adaptation in quail led to a virus
that improved its ability to shed to contacts.  Table 9 outlines the titers produced from
swabs, tracheal for quail and cloacal for chickens and mallard ducks, that were
collected on peak days of shedding. The adaptation created a virus that sheds better
than the WT H2N2.
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Table 7, Replication and Transmission of WT and Quail-adapted H2N2 in
White Leghorn Chickens
Transmission Study     Group          Day (number of positive swab samples)
                                                             1         3          5          7          9          11        15
WT H2N2 Infected Chicken 0/9 0/9 0/9 0/9 0/9 0/9 ND
Contact Chicken 0/9 0/9 0/9 0/9 0/9 0/9 ND
Passage 6 H2N2 Infected Chicken 3/9 8/9 9/9 9/9 8/9 0/9 0/9
Quail-adapted
Contact Chicken 0/9 3/9 4/9 9/9 9/9 3/9 1/9
Table 7.  WT A/Mallard/Potsdam/178-4/83 (H2N2) does not replicate or transmit in
White Leghorn chickens.  Infection with quail-adapted virus from passage 6 leads to
replication and transmission in chickens.  Infection leads to disease symptoms
including lethargy, excess mucous and diarrhea.  Experiments were run at three
separate times to confirm results.
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Table 8, Replication of WT H2N2 versus Quail-adapted H2N2 in mallard ducks
Virus    Day      Trachea Swabs Positive (out of 2)      Cloacal Swabs Positive (out of 2)
WT H2N2 1 1/2 2/2
3 1/2 2/2
5 1/2 2/2
7 1/2 1/2
Passage 6 1 0/2 0/2
Quail-adapted 3 0/2 1/2
5 0/2 1/2
7 1/2 1/2
Table 8.  Mallard ducks were infected with WT H2N2 and Quail-adapted H2N2 to
determine the ability of quail-adapted H2N2 to replicate in the virus’ natural host.
Although the Quail-adapted virus replicated in the trachea and cloaca of mallards it
did so at decreased abilities compared to the WT H2N2.
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Table 9, Viral Titers in Tracheal and Cloacal Swabs from Quai, Chickens and
Ducks
Species Virus Day Infected Contact
          (EID50/ml)                  (EID50/ml)
_____________________________________________________________________
Quail           WT H2N2    3 5 x 104 N/A
  Quail-adapted H2N2    3 1.6 x 104 2 x 103
   5 9 x 103                         9 x 104
   7              9 x 103
Chicken Quail-adapted H2N2    3 5 x 102
      5 3 x 104
   7 2 x 105  2 x 105
   9 8 x 104 2 x 105
    11 9 x 104
Mallard Ducks WT H2N2    3 2.8 x 104 /ml N/A
Quail-adapted H2N2    3 9 x 103/ml N/A
Table 9.  Tracheal (quail) and cloacal (chicken and ducks) swabs were diluted (10–1
to 10-5) and passed in embryonated chicken eggs to determine the EID50 for each
swab.  Three swab titers were averaged for each day when possible.
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4.5 Infectious Dose 50 Studies
The Egg Infectious Dose 50 (EID50) was measured for WT and quail-adapted
H2N2 viruses.  The WT virus gave 5 x107 EID50 /ml and the quail-adapted H2N2
gave1.6 x109 EID50 /ml.  Quail and chickens were infected to determine the minimal
amount of WT and quail-adapted virus needed to establish an infection in 50% of the
birds.  The quail-adapted virus required a smaller dose than the WT to establish an
infection in 50% of the birds, chickens or quail.  For quail, the dose of WT H2N2
required was 5 x102 EID50 /ml while the quail-adapted virus required a dose of
50 EID50/ml.  Concentrating the WT H2N2 virus did not aid in infecting the
chickens.  The dose of quail-adapted virus needed to infect half the chickens was
5 x 104 EID50 /ml.
4.6 RT-PCR and Sequencing of the WT A/Mallard/Potsdam/178-4/83 (H2N2)
and Quail-adapted Virus
A single amino acid change was observed on the surface proteins of the quail-
adapted virus and five other amino acid changes were detected in the internal proteins
of the virus.  The change on the surface occurred at position 170 of the HA protein in
which asparagine in the mallard virus was changed to aspartic acid in the quail-
adapted virus (N170D).  Other amino acid changes occurred in the internal proteins of
the virus, specifically PB2, PB1 and NP.  There was one change in PB2 alanine to
valine at position 588 (A588V).  Three amino acid changes occurred in PB1,
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glutamine to arginine, aspartic acid to glutamic acid and serine to isoleucine (Q268R,
D398E, S654I) and there was one in NP, alanine to threonine (A234T).  All changes
are listed in Table 10.  Neither amino acid changes nor nucleotide changes were
detected in the PA and M genes. Silent changes were observed in the NA and NS
genes. Synonymous changes observed are listed in Table 11.
4.7 Amino Acid Changes in Adaptation: Comparison to Contact Quail in
Passage 8 and Contact Chickens Infected with Quail-adapted H2N2
After two additional passages in quail, the adapted H2N2 virus did not show
any indications of further mutations at the nucleotide or amino acid level.  When
comparing the virus extracted from contact chicken swab medium passed in
embryonated chicken eggs, there was one mutation leading to an amino acid change
in the HA region, serine to tyrosine (S152Y) which is close to the change observed
during the quail adaptation (N170D).
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Table 10, Comparison of Amino Acid changes in Quail-adapted H2N2 to WT
H2N2 and Influenza Viruses from Different Animal Species
____________________________________________________________________
Gene    Position        WT  Quail-adapted         Avian   Swine     Human        Equine
PB2 588 A V A,V,T    T,I,V        I,V             T
PB1   268 Q R        Q       Q          Q    Q
398 D E           D,E*       D         D,E*    E
654 S I      S           S          S,I    S
HA 170 N D               N,D     N/A         N,D N/A
NP 234 A T     A       A           A A
_____________________________________________________________________
* Most quail viruses have E at this position. The 1997 H5N1 viruses that crossed to humans have E at
this position. N/A: not applicable
Table 10. Changes associated with the adaptation in quail are changes that
correspond to the sequences of virus from passage 5.  No additional mutations
occurred after passaging the virus two more times.  Sequences were preformed with
virus from passage 8 in quail.  Synonymous changes observed are listed in Table 11.
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Table 11, Synonymous Changes from Adaptation in Quail
Gene               No. of Nucleotide Changes   Position          WT          Quail-adapted
PB2            2    402   G      A
   1251   T      C
PB1            0
PA            0
HA           1     739   A       G
NP 2        513   T       C
   1117   C       T
NA            1     541   A       G
M 0
NS            1      371   T       C
Table 11. Nucleotide changes were observed in all genes except M and PA.  PB was
the only gene to have nonsynonymous changes without any synonymous changes.
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4.8 Clinical Symptoms Associated with Infection of Quail-adapted H2N2 in quail
and chickens
Quail infected with WT H2N2 and their cage mates showed no significant
signs of weight loss, Figure 2A.   Quail infected with the quail-adapted virus showed
a steep decrease in weight loss ranging from 2-4% at day 1 and up to 7% on day 3.
There was a noted increase of weight between day 4 and 5, Figure 2B.
Chickens infected with WT H2N2 shed no virus and gained weight
throughout the nine days.  There is a linear relationship shown in Figure 3A for the
chickens.  Chickens infected with the quail-adapted virus had a similar weight gain to
the WT chickens up until day 7.  A few chickens lost weight but there was only one
to lose more than 2%, Figure 3B.  There is less of a linear relationship in chickens
infected with the quail-adapted virus however there is a significant increase, on
average 30% between days 7 and 8.
4.9 Plaque Assays
There were no signs of changes in plaque morphology from the adaptation in
quail and subsequent infection in chickens.  Plaque size and quantity did not vary to a
significant extent when comparing the WT H2N2 to the plaques from passage 6 and
contact chickens.
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Figure 2, Weight Study in Quail Infected with Quail-adapted H2N2
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Figure 3, Weight Study in Chickens Infected with Quail-adapted H2N2
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CHAPTER 5, DISCUSSION
Influenza viruses of the H2 subtype caused a major pandemic in 1957 and
then disappeared in humans in 1968.  Similar H2N2 influenza viruses appear to have
caused an epidemic in the last quarter of the 19th century, a possible cause of the
pandemic of 1889-1890 (Mulder and Masurel, 1958).    Influenza A viruses
circulating in aquatic birds are the progenitors for most influenza A viruses in other
species.  They are considered to be the most likely source of the Hemagglutinin (HA)
genes introduced into the human population (Webster et al., 1992).  Thus, pandemic
strains of the H2 subtype would appear to have risen from avian sources.
Hemagglutinin genes of avian H2 influenza viruses are moderately variable, the
largest difference in the amino acid sequence being 15.6% (Schafer et al., 1993).
Avian H2 influenza viruses are categorized into two distinct lineages, North America
and Eurasian.  Human H2 viruses form a separate lineage, strong evidence that there
was a single introduction of a H2 gene into humans pre-1957.   Human H2 viruses are
most similar to Eurasian strains suggesting that the human pandemic H2N2 virus was
derived from an Eurasian avian virus reassorting with the human H1N1 influenza
circulating in the population at that time (Kawaoka, Krauss, and Webster, 1989;
Scholtissek et al., 1978).
Antigenic drift of human H2 influenza viruses began in 1962.  Amino acid
changes became clustered in two regions of HA1 that corresponded to antigenic sites
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while the antigenic profiles of the majority of avian H2s were conserved through
1991, closely resembling the prototype Japan 57 (H2N2) strain (Schafer et al., 1993).
Amino acid changes in avian H2 influenza strains occur throughout the HA1,
providing evidence that antibodies do not play a large role in the selection of avian
H2 viruses, much like influenza B viruses (Air et al., 1990).  Thus avian H2 virus like
that of the human pandemic strain can circulate and evolve with the avian species,
surviving to a point now where most of the human population is immune naive to H2
influenza.  Avian species have a humoral and cell mediated response to influenza
infections but antibody responses are not long lasted (Kida, Yanagawa, and
Matsuoka, 1980).  Therefore, antibody titers may be too low to allow the selection of
variants.  The H3 of the 1968 and the H2 of the 1957 pandemic are unlikely to have
been very pathogenic for poultry (Li et al., 2003).  Therefore, two-way transmission
between different types of poultry, particularly in southern China increases the
opportunity to generate an avian influenza virus with human pandemic potential.
Quail serve as an intermediate host in the formation and perpetuation of
influenza viruses crossing the species barrier.  They have been proposed to be the
“route modulator” that alters the mode of transmission from that of fecal-oral to
aerosol (Liu et al., 2003a).  Quail may have a role in the history of influenza because
of the ability of influenza viruses to replicate in trachea of quail and the quail’s
susceptibility to multiple subtypes.  It is close to impossible to confirm because
surveillance to isolate influenza from the natural pool of avian species began in the
early 1970s.
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The 1997 and 1999, human infections with H5N1 and H9N2 strains
respectively have resulted from direct transmission by land-based birds, indicating
their possible role as hosts for potential human influenza.  Quail are a member of that
group and can become infected with avian viruses and adapting them thus, permitting
replication and transmission within quail and throughout species, particularly land
based birds.  Quail infected with the highly pathogenic A/Turkey/Ontario/7732/66
(H5N9) show no clinical symptoms but can transmit the virus to chickens causing
morbidity and mortality (Slemons and Easterday, 1972; Tashiro, Reinacher, and Rott,
1987).  Quail are also more susceptible to infection with goose H5N1 than chickens.
The virus has a longer incubation in the quail, displaying clinical symptoms and death
later, therefore increasing the likelihood of transmission (Webster et al., 2002).
Viruses like A/Goose/Guangdong/1/96 (H5N1) circulating in 2003 in Southern China
replicate in the trachea of quail, transmitted by aerosol and are highly pathogenic in
the quail (Webster et al., 2002).  This particular goose H5N1 can be reintroduced in
the duck generating multiple reassortants with new aquatic gene segments (Guan et
al., 2002).  These new reassortants may be able to transmit to other hosts, particularly
terrestrial poultry, Figure 4, (Li et al., 2003).
Quail are also susceptible to mallard H9N2 influenza viruses, establishing
replication in the respiratory tract.  In contrast, chickens infected with the same 6
viruses became infected with only 2 (Perez et al., 2003a).  The infection in the
respiratory tract promotes viral shedding in the aerosol, the same method of shedding
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and transmission that occurs in mammals, particularly humans.  Thus influenza virus
infections in quail can promote a change in the tissue tropism of avian strains,
permitting the emergence of variants transmitted by aerosol (Perez et al., 2003a).
Quail have maintained a stable lineage of H9N2 influenza viruses with human virus-
like receptor specificity with the ability to infect different species of poultry
(Matrosovich, Krauss, and Webster, 2001).  Therefore, strict receptor requirements
may not be a necessity for influenza replication in other avian species.
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Figure 4, Two-way Transmission of Avian Influenza Viruses
Figure 4.  The concept of the classical gene pool and interaction between aquatic
birds and influenza viruses may be explained by interspecies transmission between
terrestrial and aquatic poultry.
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Quail can be infected with viruses from North American and Eurasian
lineages.  Quail replicated 14 of the 15 HA subtypes, the exception was a mallard
H15N8.  Replication occurred in the respiratory tract, however no virus was able to
transmit to sentinel cage mates.  Thus, additional adaptation is required for adequate
transmission among quail (Makarova et al., 2003).  Human influenza virus has been
isolated in the trachea of quail (Liu et al., 2003b).  However, experimental infections
with human H1N1 and H3N2 viruses have limited replication in quail (Makarova et
al., 2003).  This infection, without prior molecular modification, would be highly
unlikely in nature.  In contrast to the human viruses, swine influenza viruses (H1N1,
H3N2, H1N2) replicate in quail, although inefficiently, the location is in the
respiratory tract.  Therefore quail could possibly be a vehicle for avian and swine
reassortant viruses.
Though H2 influenza viruses have not been isolated from swine, transmission
of influenza from bird to human has occurred (Claas et al., 1998; Subbarao et al.,
1998; van Kolfschooten, 2003).  Interspecies transmission of influenza A viruses
among non-natural hosts, in particular land-based birds, and the factors that determine
host range are not clear.  This project sets out to define changes at the molecular level
that determine adaptation of mallard viruses in quail and what changes are necessary
for the transmission to other species, in particular chickens.
In this study we demonstrate that through adaptation in quail, a mallard
influenza virus can gain the capacity to cross species barriers into terrestrial poultry,
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an action the WT virus was unable to do.  This adaptation creates a virus that can
transmit within the quail as well as to chickens, enabling transmission to cage mates.
The genotypic changes from adaptation occur in both surface and internal genes,
confirming previous studies implicating roles for both HA and polymerase genes in
host range.  What is interesting to note is for the 1957 and 1968 human pandemics,
both surface and internal genes were exchanged, the HA, NA and PB1 for the H2N2
and the HA and PB1 for the H3N2 pandemic (Kawaoka, Krauss, and Webster, 1989;
Scholtissek et al., 1978).  The possibility of a quail-adapted virus transmitting to other
species is not new.   A/Quail/Hong Kong/A28945/88 (H9N2) was able to transmit to
other quail as well as from quail to chickens, demonstrating that a quail-adapted virus
is capable of crossing the species barrier (Perez et al., 2003a).
Quail acted as a silent host, establishing an infection of
A/Mallard/Potsdam/178-4/83 (H2N2) and maintained the role during adaptation of
that virus without clinical symptoms.   To the observer, the quail were healthy and
gaining weight.  This silent host mechanism provided insight in the virus’ ability to
go undetected in an intermediate host, much like it does in its natural host and
therefore allows the mutation and perpetuation of the virus.  In a silent and healthy
host, the virus is established and able to interact with the environment and therefore
other potential carriers.
The adaptation of the mallard virus by dosing with lung homogenate was used
to accelerate the process in nature by giving the quail concentrated virus that was able
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to replicate and establish an infection the previous group.  In this manner each
passage would be receiving a dose of virus, targeted to replicate and shed in the
respiratory tract of quail.  The adaptation of A/Mallard/Potsdam/178-4/83 (H2N2) did
not loose its ability to replicate in mallard ducks, a finding consistent with
observations that avian influenza viruses, like H9 and H5, adapted to terrestrial birds
may display a broader host range (Perez et al., 2003a).   The two-way transmission
theory proposed for avian H9N2 viruses from Li et al, 2003 can be applied here
(Figure 4).  With the ability of the quail-adapted H2N2 virus to re-infect ducks, the
virus has the potential to reassort, creating a new virus, that contains some genes of
aquatic avian origin with the potential to cross the species barrier.
The adaptation created a virus that sheds better than the WT H2N2 in quail
and chickens.  Therefore, it would be possible to maintain an infected population as
long as uninfected birds were introduced to the population whether they are quail,
chickens or ducks.  This is a huge implication that the role of live bird markets play in
the promiscuity and prevalence of influenza viruses.  The quail-adapted virus sheds
more than the WT and requires less virus for infection in both chicken and quail,
implying the amount of virus transmitting in the aerosol and fecal route for the quail
and chickens is more than enough for infection.   Efforts to concentrate the WT H2N2
virus to establish an infection in chickens proved unsuccessful indicating the changes
that occurred in the adaptation of the virus in quail are completely necessary for the
transmission to the chickens.
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Clinical symptoms of infection can aid in diagnosis and surveillance of avian
influenza however when infections involve a silent host, detection is possible only
through sampling.  Weight loss is a clinical symptom and often involved with
influenza infections.  Quail infected with the WT virus showed an overall increase in
weight and weight was gained throughout the infection.  Quail infected with the
quail-adapted virus did not respond as well.  The most drastic weight loss was on the
day of transmission and peak shedding for infected quail.  Infected quail regained
weight by day 4 and returned to their pre-infection weights by day 5, around the same
day that antibodies can be detected.  Quail that became infected with either WT or
quail-adapted virus through infection or transmission lost weight at initial days of
infection, however the quail-adapted group lost 2-5% more weight.
Weight studies in chickens displayed normal linear growth for those in the
WT group.  This is typical growth for the chickens since no infection was established.
The weight gain in the quail-adapted group was not as clear as the WT group with
some weight loss, although minimal.  What is interesting to note is that on day 7 the
chickens gained a drastic amount of weight, the majority increasing by 30%
compared to the previous day.  This weight gain may be due to two observations; a
humoral response was active and symptoms of diarrhea had ceased by 7 days post-
infection.  The chickens in the adapted group had increased their weight anywhere
from 50-80% their original weight at the end of the study whereas the WT group had
uniformly gained 45-50% of their original weight.
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Sequence analysis was performed to determine the molecular changes
associated with the transmission phenotype of the quail-adapted H2N2 virus.
Different subtypes of avian influenza have been studied to determine the minimal
changes necessary in the adaptation of influenza from waterfowl to land-based birds.
An increased number of glycosylation sites on the HA surface protein have been
associated with adaptation of H5 and H7 viruses to land-based poultry (Matrosovich
et al., 1999).  In H9 viruses there are seven amino acid positions on HA that
correspond to adaptation (Perez et al., 2003a).
For the adaptation of A/Mallard/Potsdam/178-4/83 (H2N2), a single amino
acid change was observed on the surface proteins and five other amino acid changes
were detected in the internal proteins of the virus (Table 10).  The change on the viral
surface occurred at position 170 of the HA protein in which asparagine in the mallard
virus was changed to aspartic acid in the quail-adapted virus (N170D).  This change
occurs in a region located in close proximity to the receptor-binding pocket of the
virus, nine amino acids away from glycosylation site on the HA1 subunit at position
179 (Schafer et al., 1993).  This change is not unique to the quail-adapted virus.
Human H2N2 viruses from 1962 (A/Taiwan/1/62 and A/Yokosuka/3/62) and 1967
(A/Johanesburg/567/67 and A/Montevideo/2208/67) as well as A/Japan/305/57
(H2N2) have aspartic acid in position 170.  Other amino acid changes occurred in the
internal proteins of the virus; specifically, changes were identified in the PB2, PB1,
and NP proteins.  These changes have previously been suggested to play a role in host
range in influenza viruses in mammalian and avian species (Hatta et al., 2002; Ito and
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Kawaoka, 2000; Perez and Donis, 2001; Reid et al., 2004).  Interestingly, some of the
amino acid changes detected share commonalities with amino acids found in other
terrestrial birds and with some human viruses.  Amino acid residue 588 in PB2
appears to be under selective pressure.  The majority of avian influenza viruses have
alanine in this position, whereas all human influenza viruses sequenced to date have
isoleucine.  Our quail-adapted virus contains valine in position 588 (A588V), also
found in the 2002 avian H5N1 influenza viruses that display an unusual lethality for
ducks and in the mouse adapted neurotropic A/WSN/33 (H1N1) strain.  Whether the
change in the WSN virus is a consequence of its adaptation for growth in chicken
eggs is not known.  It is important to note that valine contains an intermediate
structure between alanine and isoleucine (Figure 5).  Thus, viruses having valine at
position 588 may be at a transition state that could later favor a change in either
direction.  Further evidence that position 588 is under host selective pressure comes
from the observation that all equine influenza PB2 sequences available to date contain
threonine at this position, a feature that is shared with few duck influenza viruses and
few swine influenza viruses.
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Figure 5, Structures of Alanine (A), Valine (V) and Isoleucine (I)
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Changes at amino acid residues 268 in PB1, glutamine to arginine, and 234 in
NP, alanine to threonine, appear to be unique to the H2N2 quail-adapted virus and
further studies will be needed before any conclusion can be made about these
changes.  In contrast, amino acid position 398 in PB1 has been changed from an
aspartic acid in the mallard virus to a glutamic acid in the quail-adapted virus.
Interestingly, the majority of quail influenza isolates sequenced to date have glutamic
acid at this position, suggesting that this change may confer some selective advantage
to the virus for replication in quail.  Glutamic acid at position 398 is also found in the
PB1 gene of the 1997 H5N1 viruses that crossed to humans and in influenza A/Puerto
Rico/8/34 (H1N1) virus.  An additional change in PB1 was observed in position 654
in which serine in the mallard virus has been replaced by isoleucine in the quail-
adapted virus.  This type of change is not unique to the quail-adapted virus with at
least two human H1N1 isolates having the same amino acid: they are from 1983,
influenza A/Chile/1/83 (H1N1) and A/Fiji/15899/83 (H1N1). This A/Chile/1/83
(H1N1) was the major influenza strain reported in the 1983-84 season in the United
States.  Of the 2,130 isolates obtained by collaborating laboratories, 51% were of the
H1N1 subtype.  The number of isolates reported was the largest since the 1976-77
season (MMWR, CDC).  The mortality rate for this H1N1 outbreak was minimal and
hardly cross the epidemic threshold but could be due to the lack of reported illnesses
among the elderly, the group typically most vulnerable to severe influenza infection.
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Neither amino acid changes nor nucleotide changes were detected in the PA
and M genes. Silent changes were observed in the NA and NS genes. Synonymous
changes observed are listed in Table 11.
In summary, minor changes are responsible for the transmission phenotype of
the mallard H2N2 virus in quail and chickens. While two of these changes appear to
be unique to the quail-adapted virus, other changes show a trend during adaptation of
avian influenza in terrestrial poultry.  The results are consistent with the notion that
changes on the surface glycoproteins alone are not sufficient for transmission of avian
influenza in chickens (Makarova et al., 2003; Perez et al., 2003a; Perez et al., 2003b).
Four of the six amino acid changes are found in nature, therefore it is highly unlikely
that this adaptation was artificially created in the lab, instead it mimics what could
happen in nature.  Although two changes are not found in current sequences it does
not mean these changes are irrelevant, instead they are undefined.  Increasing the
database of avian and mammalian influenza sequences will help to highlight amino
acids that are host specific.
Sequence analysis from passage 8 in quail showed no further amino acid
changes.   There is no pressure for further mutations, indicating a virus well adapted
to its host.  In contrast, review of virus extracted from cloacal swabs from contact
chickens contained one additional change on the HA gene at position 152, serine to
tyrosine, (S152Y) which is close to the change observed during the quail adaptation
(N170D).  This change is close to the receptor binding area, but tyrosine does not
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appear to be a common amino acid in position 152 for the HAs of avian or human
influenza viruses.  Therefore, although current sequenced isolates for chickens do not
show tyrosine prevalence at this position it does not mean this mutation is irrelevant.
Live quail are no longer permitted in the live bird markets in Hong Kong.
Public authorities suspect quail transmit influenza viruses to other birds (Makarova et
al., 2003). Unfortunately markets in Mainland China and parts of Europe and the
United States continue to house many species of poultry, aquatic and terrestrial
including quail, in one location.  A market in Nanchang, China was surveyed and
labeled by Liu and colleagues as an ideal environment for the maintenance and
reassortment of influenza viruses.  This surveillance highlights quail as susceptible to
all virus subtypes isolated in the market (Liu et al., 2003b; Makarova et al., 2003).
Live bird markets pose the debate of human and animal health versus lifestyle and
culture that has been around for centuries.  In order to improve on the current
situation in Asia as well as around the world, live bird markets need increased
surveillance, proper sanitation, record keeping and separation of avian species to
prevent quail and other land-based birds from taking an active role in the perpetuation
of avian influenza strains that are capable of crossing the species barrier.
The mechanism for adaptation of mallard viruses in quail and their
transmission to other species is ill defined.  More adaptation studies like this are
needed to fully evaluate whether the changes identified here represent a trend in more
than one influenza virus strain or whether similar changes will occur in other animal
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species.  It is important to identify potential intermediate hosts and study the
mechanism to which the alteration of viruses leads to a new virus capable of crossing
the species barrier to other avian species or mammals where further mutations and
reassortment can take place.
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CHAPTER 6, CONCLUSIONS AND FUTURE WORK
6.1 Conclusions
Respiratory replication and shedding of influenza A viruses in quail promotes
changes in tissue tropism of avian influenza A viruses, thus allowing the existence of
variants that transmit by aerosol.
The key factors of influenza are six-fold; 1) wild aquatic birds are the natural
reservoir, 2) influenza viruses in these birds replicate predominantly in the respiratory
tract and shed by fecal-oral transmission, often through water, 3) there are two
established lineages for wild aquatic birds; North American and Eurasian, 4)
influenza viruses in aquatic birds have reached an evolutionary stasis while rapid
evolution occurs after transmission of influenza to a new host, 5) most interspecies
transmissions are unstable and do not lead to stable lineages, and 6) intermediate
hosts include pigs, chickens and quail.
The major findings of this research are that A/Mallard/Potsdam/178-4/83
(H2N2) established an infection in quail directly inoculated with the virus and shed
until day 3 post-infection.  No transmission to sentinel cage mates was observed.
After six passages of lung homogenate a virus arose that was adapted to quail.
Transmission to contact quail occurred on day 3 post-infection and all contact quail
became infected shedding just as much virus as the infected quail.
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Quail-adapted H2N2 virus established an infection and transmitted to White
Leghorn chickens while in contrast the original, wild type, A/Mallard/Postdam/178-
4/83 (H2N2) was unable to establish an infection even in chickens directly inoculated
with virus.  Quail-adapted H2N2 was able to establish an infection in mallard ducks.
Changes occurred at both surface and internal genes, including the HA, PB2, PB1 and
NP genes.
Live bird markets like those in Southeast Asia, as well as other parts of the
world, including Europe and North America need to be updated to fit the needs of the
animals as well as the humans partaking in them.  It is a cultural barrier necessary to
cross in order to protect both poultry and humans from the optimal breeding ground
for influenza virus reassortment and interspecies transmission.  We have highlighted
in this study how quail can take a mallard virus and adapt it to become a virus that
establishes infection in quail and can transmit from the quail to chickens and ducks,
enabling the virus the potential to reassort and spread.  Governments across the world
have the responsibility to set plans in action to increase surveillance and education of
avian influenza to their public.  Further research is necessary to outline methods of
transmission of influenza viruses from avian species to humans, across all potential
influenza subtypes, not just the current issues of H5N1 influenza viruses.
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6.2 Future Work
Future work for determining key genes in the transmission of
A/Mallard/Potsdam/178-4/83 (H2N2), to quail as well as to chickens includes cloning
the WT and Quail-adapted viruses using reverse genetics outlined by Hoffmann,
(Hoffmann et al., 2002)
Immediate work would involve cloning all eight genes of the WT H2N2 influenza
virus and substituting each gene that contained amino acid changes in the adaptation
in quail.  Viruses prepared through reverse genetics are listed below:
1) WT + PB2, PB1, HA quail-adapted
2) WT + PB1, HA quail-adapted
3) WT + HA quail-adapted
If one of the combinations above proved to be a reassortant capable of transmission
then with each quail-adapted gene included one at a time would be replaced by a WT
gene to see what composition was responsible for transmission.  If the gene
highlighted was one where multiple amino acid changes occurred, each change would
be reverted back to the WT amino acid at a time to determine if one or more amino
acid was implicated in the adaptation.  When the composition for transmission in
quail is identified that same virus will be tested in chickens to determine if the
minimal changes necessary for quail are the same for chickens.
94
Later work important to understanding H2N2 influenza viruses would include
testing other mallard viruses from both lineages, Eurasian and North American, to
determine if similar amino acid changes are necessary for adaptation in quail.  It is
also important to determine if similar adaptations can occur from mallard ducks to
chickens and if those chicken-adapted viruses can transmit to quail.  Other influenza
subtypes that pose a threat to humans such as the H5, H7 and H9 viruses should also
be studied to determine the ability of these viruses to transmit across avian species
and what changes occur at the protein level when adapting these viruses in quail.
Additional studies should include developing a mammalian model, such as
ferrets, to determine what changes occur at the molecular level to allow these quail-
adapted and avian H2N2 influenza viruses to infect and transmit in mammals.
Identifying the necessary changes will aid in combating and preventing future human
infections with H2N2 influenza viruses.
95
REFERENCES
Air, G. M., Gibbs, A. J., Laver, W. G., and Webster, R. G. (1990). Evolutionary
changes in influenza B are not primarily governed by antibody selection. Proc
Natl Acad Sci U S A 87(10), 3884-8.
Area, E., Martin-Benito, J., Gastaminza, P., Torreira, E., Valpuesta, J. M., Carrascosa,
J. L., and Ortin, J. (2004). 3D structure of the influenza virus polymerase
complex: localization of subunit domains. Proc Natl Acad Sci U S A 101(1),
308-13.
Bancroft, C. T., and Parslow, T. G. (2002). Evidence for segment-nonspecific
packaging of the influenza a virus genome. J Virol 76(14), 7133-9.
Beare, A. S., and Webster, R. G. (1991). Replication of avian influenza viruses in
humans. Arch Virol 119(1-2), 37-42.
Biswas, S. K., and Nayak, D. P. (1994). Mutational analysis of the conserved motifs
of influenza A virus polymerase basic protein 1. J Virol 68(3), 1819-26.
Braam, J., Ulmanen, I., and Krug, R. M. (1983). Molecular model of a eucaryotic
transcription complex: functions and movements of influenza P proteins
during capped RNA-primed transcription. Cell 34(2), 609-18.
Bron, R., Kendal, A. P., Klenk, H. D., and Wilschut, J. (1993). Role of the M2 protein
in influenza virus membrane fusion: effects of amantadine and monensin on
fusion kinetics. Virology 195(2), 808-11.
Brown, I. H. (2000). The epidemiology and evolution of influenza viruses in pigs. Vet
Microbiol 74(1-2), 29-46.
Brown, P., Gajdusek, D. C., and Morris, J. A. (1966). Epidemic A2 influenza in
isolated Pacific island populations without pre-epidemic antibody to influenza
virus types A and B, and the discovery of other still unexposed populations.
Am J Epidemiol 83(1), 176-88.
Buonagurio, D. A., Nakada, S., Desselberger, U., Krystal, M., and Palese, P. (1985).
Noncumulative sequence changes in the hemagglutinin genes of influenza C
virus isolates. Virology 146(2), 221-32.
96
Chin, P. S., Hoffmann, E., Webby, R., Webster, R. G., Guan, Y., Peiris, M., and
Shortridge, K. F. (2002). Molecular evolution of H6 influenza viruses from
poultry in Southeastern China: prevalence of H6N1 influenza viruses
possessing seven A/Hong Kong/156/97 (H5N1)-like genes in poultry. J Virol
76(2), 507-16.
Claas, E. C., Osterhaus, A. D., van Beek, R., De Jong, J. C., Rimmelzwaan, G. F.,
Senne, D. A., Krauss, S., Shortridge, K. F., and Webster, R. G. (1998). Human
influenza A H5N1 virus related to a highly pathogenic avian influenza virus.
Lancet 351(9101), 472-7.
Colman, P. M., and Lawrence, M. C. (2003). The structural biology of type I viral
membrane fusion. Nat Rev Mol Cell Biol 4(4), 309-19.
Colman, P. M., Tulip, W. R., Varghese, J. N., Tulloch, P. A., Baker, A. T., Laver, W.
G., Air, G. M., and Webster, R. G. (1989). Three-dimensional structures of
influenza virus neuraminidase-antibody complexes. Philos Trans R Soc Lond
B Biol Sci 323(1217), 511-8.
Cox, N. J., Bai, Z. S., and Kendal, A. P. (1983). Laboratory-based surveillance of
influenza A(H1N1) and A(H3N2) viruses in 1980-81: antigenic and genomic
analyses. Bull World Health Organ 61(1), 143-52.
Cox, N. J., and Subbarao, K. (2000). Global epidemiology of influenza: past and
present. Annu Rev Med 51, 407-21.
Easterday, B. C. (1975). Antigens (and recombinants) and immune response to avian
influenza. Am J Vet Res 36(4 Pt 2), 503-4.
Enami, M., Sharma, G., Benham, C., and Palese, P. (1991). An influenza virus
containing nine different RNA segments. Virology 185(1), 291-8.
Gambaryan, A., Webster, R., and Matrosovich, M. (2002). Differences between
influenza virus receptors on target cells of duck and chicken. Arch Virol
147(6), 1197-208.
Govorkova, E. A., Kizina, A. A., Krylov, V. F., and Smirnov Iu, A. (1993). [The level
of population immunity to influenza A viruses with hemagglutinin subtype
H2]. Zh Mikrobiol Epidemiol Immunobiol(6), 58-9.
Guan, Y., Peiris, M., Kong, K. F., Dyrting, K. C., Ellis, T. M., Sit, T., Zhang, L. J.,
and Shortridge, K. F. (2002). H5N1 influenza viruses isolated from geese in
Southeastern China: evidence for genetic reassortment and interspecies
transmission to ducks. Virology 292(1), 16-23.
97
Guan, Y., Shortridge, K. F., Krauss, S., Chin, P. S., Dyrting, K. C., Ellis, T. M.,
Webster, R. G., and Peiris, M. (2000). H9N2 influenza viruses possessing
H5N1-like internal genomes continue to circulate in poultry in southeastern
China. J Virol 74(20), 9372-80.
Guan, Y., Shortridge, K. F., Krauss, S., and Webster, R. G. (1999). Molecular
characterization of H9N2 influenza viruses: were they the donors of the
"internal" genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci U S A
96(16), 9363-7.
Guo, Y., Wang, M., Kawaoka, Y., Gorman, O., Ito, T., Saito, T., and Webster, R. G.
(1992). Characterization of a new avian-like influenza A virus from horses in
China. Virology 188(1), 245-55.
Guo, Y. J., Krauss, S., Senne, D. A., Mo, I. P., Lo, K. S., Xiong, X. P., Norwood, M.,
Shortridge, K. F., Webster, R. G., and Guan, Y. (2000). Characterization of
the pathogenicity of members of the newly established H9N2 influenza virus
lineages in Asia. Virology 267(2), 279-88.
Hatta, M., Halfmann, P., Wells, K., and Kawaoka, Y. (2002). Human influenza a viral
genes responsible for the restriction of its replication in duck intestine.
Virology 295(2), 250-5.
Hay, A. J. (1974). Studies on the formation of the influenza virus envelope. Virology
60(2), 398-418.
Hinshaw, V. S., Bean, W. J., Geraci, J., Fiorelli, P., Early, G., and Webster, R. G.
(1986). Characterization of two influenza A viruses from a pilot whale. J Virol
58(2), 655-6.
Hinshaw, V. S., Bean, W. J., Webster, R. G., and Sriram, G. (1980a). Genetic
reassortment of influenza A viruses in the intestinal tract of ducks. Virology
102(2), 412-9.
Hinshaw, V. S., Webster, R. G., Bean, W. J., and Sriram, G. (1980b). The ecology of
influenza viruses in ducks and analysis of influenza viruses with monoclonal
antibodies. Comp Immunol Microbiol Infect Dis 3(1-2), 155-64.
Hinshaw, V. S., Webster, R. G., Naeve, C. W., and Murphy, B. R. (1983). Altered
tissue tropism of human-avian reassortant influenza viruses. Virology 128(1),
260-3.
Hobman, T. C. (1993). Targeting of viral glycoproteins to the Golgi complex. Trends
Microbiol 1(4), 124-30.
98
Hoffmann, E., Krauss, S., Perez, D., Webby, R., and Webster, R. G. (2002). Eight-
plasmid system for rapid generation of influenza virus vaccines. Vaccine
20(25-26), 3165-70.
Hoffmann, E., Stech, J., Guan, Y., Webster, R. G., and Perez, D. R. (2001). Universal
primer set for the full-length amplification of all influenza A viruses. Arch
Virol 146(12), 2275-89.
Hoffmann, E., Stech, J., Leneva, I., Krauss, S., Scholtissek, C., Chin, P. S., Peiris, M.,
Shortridge, K. F., and Webster, R. G. (2000). Characterization of the influenza
A virus gene pool in avian species in southern China: was H6N1 a derivative
or a precursor of H5N1? J Virol 74(14), 6309-15.
Honda, A., Mukaigawa, J., Yokoiyama, A., Kato, A., Ueda, S., Nagata, K., Krystal,
M., Nayak, D. P., and Ishihama, A. (1990). Purification and molecular
structure of RNA polymerase from influenza virus A/PR8. J Biochem (Tokyo)
107(4), 624-8.
Honda, A., Ueda, K., Nagata, K., and Ishihama, A. (1988). RNA polymerase of
influenza virus: role of NP in RNA chain elongation. J Biochem (Tokyo)
104(6), 1021-6.
Horimoto, T., and Kawaoka, Y. (1995). The hemagglutinin cleavability of a virulent
avian influenza virus by subtilisin-like endoproteases is influenced by the
amino acid immediately downstream of the cleavage site. Virology 210(2),
466-70.
Huang, T. S., Palese, P., and Krystal, M. (1990). Determination of influenza virus
proteins required for genome replication. J Virol 64(11), 5669-73.
Ito, T., Couceiro, J. N., Kelm, S., Baum, L. G., Krauss, S., Castrucci, M. R.,
Donatelli, I., Kida, H., Paulson, J. C., Webster, R. G., and Kawaoka, Y.
(1998). Molecular basis for the generation in pigs of influenza A viruses with
pandemic potential. J Virol 72(9), 7367-73.
Ito, T., and Kawaoka, Y. (2000). Host-range barrier of influenza A viruses. Vet
Microbiol 74(1-2), 71-5.
Kawaoka, Y., Krauss, S., and Webster, R. G. (1989). Avian-to-human transmission of
the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol
63(11), 4603-8.
Kida, H., Ito, T., Yasuda, J., Shimizu, Y., Itakura, C., Shortridge, K. F., Kawaoka, Y.,
and Webster, R. G. (1994). Potential for transmission of avian influenza
viruses to pigs. J Gen Virol 75 ( Pt 9), 2183-8.
99
Kida, H., Yanagawa, R., and Matsuoka, Y. (1980). Duck influenza lacking evidence
of disease signs and immune response. Infect Immun 30(2), 547-53.
Kido, H., Murakami, M., Oba, K., Chen, Y., and Towatari, T. (1999). Cellular
proteinases trigger the infectivity of the influenza A and Sendai viruses. Mol
Cells 9(3), 235-44.
Kilbourne, E. D. (1963). Influenza. Med Sci 13, 527-40.
Klenk, H. D. (1974). Viral envelopes and their relationship to cellular membranes.
Curr Top Microbiol Immunol(68), 29-58.
Kobayashi, M., Toyoda, T., and Ishihama, A. (1996). Influenza virus PB1 protein is
the minimal and essential subunit of RNA polymerase. Arch Virol 141(3-4),
525-39.
Li, K. S., Xu, K. M., Peiris, J. S., Poon, L. L., Yu, K. Z., Yuen, K. Y., Shortridge, K.
F., Webster, R. G., and Guan, Y. (2003). Characterization of H9 subtype
influenza viruses from the ducks of southern China: a candidate for the next
influenza pandemic in humans? J Virol 77(12), 6988-94.
Li, M. L., Rao, P., and Krug, R. M. (2001). The active sites of the influenza cap-
dependent endonuclease are on different polymerase subunits. Embo J 20(8),
2078-86.
Lin, Y. P., Shaw, M., Gregory, V., Cameron, K., Lim, W., Klimov, A., Subbarao, K.,
Guan, Y., Krauss, S., Shortridge, K., Webster, R., Cox, N., and Hay, A.
(2000). Avian-to-human transmission of H9N2 subtype influenza A viruses:
relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U
S A 97(17), 9654-8.
Liu, C., Eichelberger, M. C., Compans, R. W., and Air, G. M. (1995). Influenza type
A virus neuraminidase does not play a role in viral entry, replication,
assembly, or budding. J Virol 69(2), 1099-106.
Liu, J. H., Okazaki, K., Bai, G. R., Shi, W. M., Mweene, A., and Kida, H. (2004).
Interregional transmission of the internal protein genes of H2 influenza virus
in migratory ducks from North America to Eurasia. Virus Genes 29(1), 81-6.
Liu, M., Guan, Y., Peiris, M., He, S., Webby, R. J., Perez, D., and Webster, R. G.
(2003a). The quest of influenza A viruses for new hosts. Avian Dis 47(3
Suppl), 849-56.
Liu, M., He, S., Walker, D., Zhou, N., Perez, D. R., Mo, B., Li, F., Huang, X.,
Webster, R. G., and Webby, R. J. (2003b). The influenza virus gene pool in a
poultry market in South central china. Virology 305(2), 267-75.
100
Mahy, B. W., Siddell, S., Wege, H., and ter Meulen, V. (1983). RNA-dependent RNA
polymerase activity in murine coronavirus-infected cells. J Gen Virol 64 (Pt
1), 103-11.
Makarova, N. V., Kaverin, N. V., Krauss, S., Senne, D., and Webster, R. G. (1999).
Transmission of Eurasian avian H2 influenza virus to shorebirds in North
America. J Gen Virol 80 ( Pt 12), 3167-71.
Makarova, N. V., Ozaki, H., Kida, H., Webster, R. G., and Perez, D. R. (2003).
Replication and transmission of influenza viruses in Japanese quail. Virology
310(1), 8-15.
Matrosovich, M., and Klenk, H. D. (2003). Natural and synthetic sialic acid-
containing inhibitors of influenza virus receptor binding. Rev Med Virol 13(2),
85-97.
Matrosovich, M., Tuzikov, A., Bovin, N., Gambaryan, A., Klimov, A., Castrucci, M.
R., Donatelli, I., and Kawaoka, Y. (2000). Early alterations of the receptor-
binding properties of H1, H2, and H3 avian influenza virus hemagglutinins
after their introduction into mammals. J Virol 74(18), 8502-12.
Matrosovich, M., Zhou, N., Kawaoka, Y., and Webster, R. (1999). The surface
glycoproteins of H5 influenza viruses isolated from humans, chickens, and
wild aquatic birds have distinguishable properties. J Virol 73(2), 1146-55.
Matrosovich, M. N., Krauss, S., and Webster, R. G. (2001). H9N2 influenza A
viruses from poultry in Asia have human virus-like receptor specificity.
Virology 281(2), 156-62.
Mori, I., Komatsu, T., Takeuchi, K., Nakakuki, K., Sudo, M., and Kimura, Y. (1995).
Viremia induced by influenza virus. Microb Pathog 19(4), 237-44.
Mulder, J., and Masurel, N. (1958). Pre-epidemic antibody against 1957 strain of
Asiatic influenza in serum of older people living in the Netherlands. Lancet
1(7025), 810-4.
Muller, R., Poch, O., Delarue, M., Bishop, D. H., and Bouloy, M. (1994). Rift Valley
fever virus L segment: correction of the sequence and possible functional role
of newly identified regions conserved in RNA-dependent polymerases. J Gen
Virol 75 ( Pt 6), 1345-52.
Nardelli, L., Rinaldi, A., Pereira, H. G., and Mandelli, G. (1970). [Influenza virus
infections in Japanese quails]. Arch Exp Veterinarmed 24, 231-49.
Nayak, D. P., and Barman, S. (2002). Role of lipid rafts in virus assembly and
budding. Adv Virus Res 58, 1-28.
101
Nayak, D. P., and Hui, E. K. (2004). The role of lipid microdomains in virus biology.
Subcell Biochem 37, 443-91.
Neumann, G., Hughes, M. T., and Kawaoka, Y. (2000). Influenza A virus NS2
protein mediates vRNP nuclear export through NES-independent interaction
with hCRM1. Embo J 19(24), 6751-8.
Peiris, M., Yuen, K. Y., Leung, C. W., Chan, K. H., Ip, P. L., Lai, R. W., Orr, W. K.,
and Shortridge, K. F. (1999). Human infection with influenza H9N2. Lancet
354(9182), 916-7.
Perales, B., Sanz-Ezquerro, J. J., Gastaminza, P., Ortega, J., Santaren, J. F., Ortin, J.,
and Nieto, A. (2000). The replication activity of influenza virus polymerase is
linked to the capacity of the PA subunit to induce proteolysis. J Virol 74(3),
1307-12.
Perez, D. R., and Donis, R. O. (2001). Functional analysis of PA binding by influenza
a virus PB1: effects on polymerase activity and viral infectivity. J Virol
75(17), 8127-36.
Perez, D. R., Lim, W., Seiler, J. P., Yi, G., Peiris, M., Shortridge, K. F., and Webster,
R. G. (2003a). Role of quail in the interspecies transmission of H9 influenza A
viruses: molecular changes on HA that correspond to adaptation from ducks to
chickens. J Virol 77(5), 3148-56.
Perez, D. R., Webby, R. J., Hoffmann, E., and Webster, R. G. (2003b). Land-based
birds as potential disseminators of avian mammalian reassortant influenza A
viruses. Avian Dis 47(3 Suppl), 1114-7.
Pinto, L. H., Holsinger, L. J., and Lamb, R. A. (1992). Influenza virus M2 protein has
ion channel activity. Cell 69(3), 517-28.
Poon, L. L., Pritlove, D. C., Fodor, E., and Brownlee, G. G. (1999). Direct evidence
that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative
copying of a U track in the virion RNA template. J Virol 73(4), 3473-6.
Portela, A., and Digard, P. (2002). The influenza virus nucleoprotein: a
multifunctional RNA-binding protein pivotal to virus replication. J Gen Virol
83(Pt 4), 723-34.
Reid, A. H., Fanning, T. G., Hultin, J. V., and Taubenberger, J. K. (1999). Origin and
evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc
Natl Acad Sci U S A 96(4), 1651-6.
102
Reid, A. H., Fanning, T. G., Janczewski, T. A., Lourens, R. M., and Taubenberger, J.
K. (2004). Novel origin of the 1918 pandemic influenza virus nucleoprotein
gene. J Virol 78(22), 12462-70.
Reid, A. H., Fanning, T. G., Janczewski, T. A., McCall, S., and Taubenberger, J. K.
(2002). Characterization of the 1918 "Spanish" influenza virus matrix gene
segment. J Virol 76(21), 10717-23.
Reid, A. H., Fanning, T. G., Janczewski, T. A., and Taubenberger, J. K. (2000).
Characterization of the 1918 "Spanish" influenza virus neuraminidase gene.
Proc Natl Acad Sci U S A 97(12), 6785-90.
Rogers, G. N., and Paulson, J. C. (1983). Receptor determinants of human and animal
influenza virus isolates: differences in receptor specificity of the H3
hemagglutinin based on species of origin. Virology 127(2), 361-73.
Saito, T., Kawaoka, Y., and Webster, R. G. (1993). Phylogenetic analysis of the N8
neuraminidase gene of influenza A viruses. Virology 193(2), 868-76.
Schafer, J. R., Kawaoka, Y., Bean, W. J., Suss, J., Senne, D., and Webster, R. G.
(1993). Origin of the pandemic 1957 H2 influenza A virus and the persistence
of its possible progenitors in the avian reservoir. Virology 194(2), 781-8.
Scholtissek, C., Burger, H., Bachmann, P. A., and Hannoun, C. (1983). Genetic
relatedness of hemagglutinins of the H1 subtype of influenza A viruses
isolated from swine and birds. Virology 129(2), 521-3.
Scholtissek, C., Hinshaw, V. S., and Olsen, C. W. (1998). Influenza in Pigs and their
role as the intermediate host. In "Textbook of Influenza" (A. J. Hay, Ed.), pp.
137-145. Blackwell Science Ltd., Oxford.
Scholtissek, C., Rohde, W., Von Hoyningen, V., and Rott, R. (1978). On the origin of
the human influenza virus subtypes H2N2 and H3N2. Virology 87(1), 13-20.
Schulman, J. L., and Palese, P. (1977). Virulence factors of influenza A viruses: WSN
virus neuraminidase required for plaque production in MDBK cells. J Virol
24(1), 170-6.
Shapiro, G. I., Gurney, T., Jr., and Krug, R. M. (1987). Influenza virus gene
expression: control mechanisms at early and late times of infection and
nuclear-cytoplasmic transport of virus-specific RNAs. J Virol 61(3), 764-73.
Shortridge, K. F. (1999). Poultry and the influenza H5N1 outbreak in Hong Kong,
1997: abridged chronology and virus isolation. Vaccine 17 Suppl 1, S26-9.
103
Shortridge, K. F., Webster, R. G., Butterfield, W. K., and Campbell, C. H. (1977).
Persistence of Hong Kong influenza virus variants in pigs. Science 196(4297),
1454-5.
Shortridge, K. F., Zhou, N. N., Guan, Y., Gao, P., Ito, T., Kawaoka, Y., Kodihalli, S.,
Krauss, S., Markwell, D., Murti, K. G., Norwood, M., Senne, D., Sims, L.,
Takada, A., and Webster, R. G. (1998). Characterization of avian H5N1
influenza viruses from poultry in Hong Kong. Virology 252(2), 331-42.
Skehel, J. J. (1972). Polypeptide synthesis in influenza virus-infected cells. Virology
49(1), 23-36.
Skehel, J. J., and Wiley, D. C. (2000). Receptor binding and membrane fusion in
virus entry: the influenza hemagglutinin. Annu Rev Biochem 69, 531-69.
Slemons, R. D., and Easterday, B. C. (1972). Host response differences among 5
avian species to an influenzavirus--A-turkey-Ontario-7732-66 (Hav5N?). Bull
World Health Organ 47(4), 521-5.
Smith, G. L., and Hay, A. J. (1982). Replication of the influenza virus genome.
Virology 118(1), 96-108.
Stegmann, T. (2000). Membrane fusion mechanisms: the influenza hemagglutinin
paradigm and its implications for intracellular fusion. Traffic 1(8), 598-604.
Suarez, D. L., Garcia, M., Latimer, J., Senne, D., and Perdue, M. (1999).
Phylogenetic analysis of H7 avian influenza viruses isolated from the live bird
markets of the Northeast United States. J Virol 73(5), 3567-73.
Subbarao, K., and Katz, J. (2000). Avian influenza viruses infecting humans. Cell
Mol Life Sci 57(12), 1770-84.
Subbarao, K., Klimov, A., Katz, J., Regnery, H., Lim, W., Hall, H., Perdue, M.,
Swayne, D., Bender, C., Huang, J., Hemphill, M., Rowe, T., Shaw, M., Xu,
X., Fukuda, K., and Cox, N. (1998). Characterization of an avian influenza A
(H5N1) virus isolated from a child with a fatal respiratory illness. Science
279(5349), 393-6.
Sugiura, A., and Ueda, M. (1980). Neurovirulence of influenza virus in mice. I.
Neurovirulence of recombinants between virulent and avirulent virus strains.
Virology 101(2), 440-9.
Sugrue, R. J., and Hay, A. J. (1991). Structural characteristics of the M2 protein of
influenza A viruses: evidence that it forms a tetrameric channel. Virology
180(2), 617-24.
104
Tashiro, M., Reinacher, M., and Rott, R. (1987). Aggravation of pathogenicity of an
avian influenza virus by adaptation to quails. Arch Virol 93(1-2), 81-95.
Ulmanen, I., Broni, B. A., and Krug, R. M. (1981). Role of two of the influenza virus
core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in
initiating viral RNA transcription. Proc Natl Acad Sci U S A 78(12), 7355-9.
van Kolfschooten, F. (2003). Dutch veterinarian becomes first victim of avian
influenza. Lancet 361(9367), 1444.
Webby, R., Hoffmann, E., and Webster, R. (2004). Molecular constraints to
interspecies transmission of viral pathogens. Nat Med 10(12 Suppl), S77-81.
Webby, R. J., and Webster, R. G. (2001). Emergence of influenza A viruses. Philos
Trans R Soc Lond B Biol Sci 356(1416), 1817-28.
Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., and Kawaoka, Y.
(1992). Evolution and ecology of influenza A viruses. Microbiol Rev 56(1),
152-79.
Webster, R. G., Guan, Y., Peiris, M., Walker, D., Krauss, S., Zhou, N. N.,
Govorkova, E. A., Ellis, T. M., Dyrting, K. C., Sit, T., Perez, D. R., and
Shortridge, K. F. (2002). Characterization of H5N1 influenza viruses that
continue to circulate in geese in southeastern China. J Virol 76(1), 118-26.
Webster, R. G., Hinshaw, V. S., Bean, W. J., Van Wyke, K. L., Geraci, J. R., St
Aubin, D. J., and Petursson, G. (1981). Characterization of an influenza A
virus from seals. Virology 113(2), 712-24.
Webster, R. G., Yakhno, M., Hinshaw, V. S., Bean, W. J., and Murti, K. G. (1978).
Intestinal influenza: replication and characterization of influenza viruses in
ducks. Virology 84(2), 268-78.
Wilson, R., Miller, J., Greene, H., Rankin, R., Lumeng, L., Gordon, D., Nelson, D.,
and Noble, G. (1980). Reye's syndrome in three siblings. Association with
type A influenza infection. Am J Dis Child 134(11), 1032-4.
Yamashita, M., Krystal, M., Fitch, W. M., and Palese, P. (1988). Influenza B virus
evolution: co-circulating lineages and comparison of evolutionary pattern with
those of influenza A and C viruses. Virology 163(1), 112-22.
Yuen, K. Y., Chan, P. K., Peiris, M., Tsang, D. N., Que, T. L., Shortridge, K. F.,
Cheung, P. T., To, W. K., Ho, E. T., Sung, R., and Cheng, A. F. (1998).
Clinical features and rapid viral diagnosis of human disease associated with
avian influenza A H5N1 virus. Lancet 351(9101), 467-71.
105
Zebedee, S. L., and Lamb, R. A. (1988). Influenza A virus M2 protein: monoclonal
antibody restriction of virus growth and detection of M2 in virions. J Virol
62(8), 2762-72.
Zheng, H., Lee, H. A., Palese, P., and Garcia-Sastre, A. (1999). Influenza A virus
RNA polymerase has the ability to stutter at the polyadenylation site of a viral
RNA template during RNA replication. J Virol 73(6), 5240-3.
